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Abstract 
Approximately 50% of antibiotics prescribed are not necessary, nevertheless in the United States 
among the many outpatient prescriptions, few are more widely prescribed than antibiotics.  The 
inappropriate use of antibiotics to treat non-bacterial infections has been largely responsible for 
the emergence of antibiotic resistance.  The purpose of this DNP project was to evaluate the 
effect of an antibiotic stewardship program on urgent care providers’ antibiotic prescribing for 
acute respiratory infections and to analyze providers’ awareness and beliefs regarding antibiotic 
use and resistance.  A quasi-experimental study was conducted among a convenience sample of 
eight urgent care providers who received a one hour theory-based intervention program on 
antibiotic prescribing.  Outcomes measured included provider antibiotic prescribing rates pre- 
and post-intervention, differences in antibiotic prescribing among the providers, and provider 
attitude and knowledge regarding antibiotic prescribing and resistance.  The antibiotic 
prescribing rate decreased from 30% to 20% post-intervention, p =. 078.  The odds ratio of nurse 
practitioners preferring not to prescribe antibiotics pre-intervention was 3.273 (p = .001) and 
post-intervention 4.155 (p = < .0005) times more than physicians.  Within their setting, 84.43% 
believed antibiotics are overused, and 92.25% believed antibiotic resistance is a problem.  
Implementation of an outpatient antibiotic stewardship program is necessary to decrease 
inappropriate antibiotic prescribing, slow progression of antibiotic resistance, and decrease 
healthcare costs associated with this world-wide public health problem.     
Keywords: academic detailing, antibiotic resistance, antibiotic overuse, acute respiratory 
tract infections, antibiotic stewardship, knowledge, attitude and practice surveys, intervention, 
outpatient  
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Reducing Outpatient Antibiotic Resistance: A Quasi-Experimental Study 
Antibiotic resistance is a phenomenon that happens when an antibiotic loses the ability to 
successfully eradicate bacterial growth (Institute of Medicine [IOM], 2010), which was 
identified as early as 1940 with penicillin-R Staphylococcus prior to the widespread use of 
penicillin in 1943 (Centers for Disease Control and Prevention [CDC], 2013).  The emergence of 
drug-resistant bacteria can be attributed to the evolution of microbes and to inappropriate use of 
antibiotics to treat non-bacterial infections (Agency for Healthcare Research and Quality 
[AHRQ], 2014; CDC, 2013; Charani et al., 2011; Van Boeckel et al., 2014).  Antibiotic 
resistance is a worldwide community health crisis reducing the efficacy of antibiotics to 
adequately treat infections, increasing patient mortality and skyrocketing healthcare costs (CDC, 
2013; Center for Disease Dynamics, Economics & Policy, 2015; IOM, 2010; World Health 
Organization [WHO], 2014).  To preserve antibiotic effectiveness and decrease antibiotic 
resistance, coordinated interventions involving healthcare providers can be provided through 
antibiotic stewardship programs (CDC, 2013; Griffith, Postelnick, & Scheetz, 2012).   
Significance of Antibiotic Stewardship 
Overuse of antibiotics in healthcare has become an increasingly costly problem within the 
United States contributing to the high costs of healthcare and subjecting patients to unwarranted 
adverse events and health risks (Berwick & Hackbarth, 2012; Powell, Bloomfield, Burgess, Wilt, 
& Partin, 2013).  Acute respiratory infections (ARI), typically viral in nature, are some of the 
most common illnesses presenting to outpatient providers (Harris, Hicks, & Qaseem, 2016).  In 
2011, there was an estimated 4.6 million emergency department (ED) and 3.3 million outpatient 
visits for ARIs with the number of antibiotic prescriptions totaling almost 9.3 million (CDC, 
2014a, b, c, d).  In 2012, an estimated $1 billion of US healthcare spending was incurred through 
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antibiotic prescriptions (IMS Institute for Healthcare Informatics [IMS Institute], 2013).  In the 
United States, antibiotic resistant infections represent over 2 million illnesses and at least 23,000 
deaths yearly (CDC, 2013), leading annually to $35 billion in lost wages and an excess of 8 
million unnecessary hospital days, costing the healthcare system more than $20 billion a year 
(CDC, 2011).  Due to the increase in antibiotic use and resistance, healthcare costs, and patient 
disability and mortality, aggressive action is necessary to prevent the spread and the development 
of new antibiotic resistance (CDC, 2013).  Therefore, in March 2015, the Interagency Task Force 
on Antimicrobial Resistance presented the National Action Plan for Combating Antibiotic-
Resistant Bacteria providing a roadmap to detect, prevent, and control antibiotic resistance by 
guiding activities to improve antimicrobial stewardship to reduce outpatient inappropriate 
antibiotic use by 50% by 2020 (The White House, 2015).   
Local Issue 
Urgent Care providers attend to numerous patients with ARIs on a yearly basis.  
According to the National Hospital Ambulatory Medical Care Survey (NHAMCS), in 2011, 
ARIs accounted for 3.5% of people in the ED and 2.6% of people in outpatient facilities (CDC, 
2014c; CDC, 2014d).  At the project site institution, during 2015, approximately 31,780 people 
were seen in the ED and 101,991 people seen in the seven urgent care facilities (Hospital, 2015).  
Using the percentages from the NHAMCS, approximately 1,112 patients seen in the ED and 
2,652 patients seen in the urgent care facilities were possibly diagnosed with ARIs.  At the 
project site facility, there is no formal educational seminar for healthcare providers regarding 
antibiotic stewardship. The student investigator contends that development and utilization of an 
outpatient antibiotic stewardship program would promote judicious use of antibiotics for ARIs by 
healthcare providers within urgent care centers and EDs.  
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Diversity Considerations 
Healthcare providers come from diverse backgrounds and possess a mixture of customary 
beliefs, practices and attitudes that can impact the quality of patient care (Lehman et al., 2012).  
The eight urgent care centers to be studied are staffed by 59 healthcare providers consisting of 24 
physicians (MDs) and 35 nurse practitioners (NPs), and each provider has different levels of 
training and years in practice.  The DNP study evaluated whether there was a difference in the 
antibiotic prescribing habits and knowledge of antibiotic resistance and antibiotic decision 
making process between NPs and MDs.   
Problem 
Approximately 50% of antibiotics prescribed are not necessary (AHRQ, 2014; CDC, 
2013), nevertheless, in the United States among the many outpatient prescription medications, 
few are more widely prescribed than antibiotics (Gerber et al., 2013; Lee et al., 2014).  Between 
2000 and 2010, global consumption of antibiotics increased by 36%, and the United States was 
the third largest consumer with an estimated 9.2% of global consumption (Van Boeckel et al., 
2014).  Lee et al. (2014) revealed in the United States from 2000 to 2010 that approximately 3.1 
billion outpatient ARI visits occurred with an estimated 1.4 billion outpatient antibiotics 
prescribed and ARIs accounted for 75% of all antibiotics prescribed by office-based providers.  
Most antibiotic use occurs in the outpatient setting; therefore, it is imperative to understand 
factors which influence prescribing decisions, apply antibiotic stewardship principles to 
ambulatory care settings, decrease inappropriate antibiotic prescribing, slow progression of 
antibiotic resistance, and reduce healthcare costs associated with this global public health 
problem.   
Intended Improvement, Purpose 
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Antibiotic resistance is commonly ignored because many healthcare providers do not 
regard this problem as an important priority in practice (Bekkers et al., 2010).  Inappropriate use 
of antibiotics can be associated with healthcare providers’ lack of knowledge, attitudes regarding 
antibiotic use and resistance, and intrinsic or extrinsic factors that can influence prescribing 
decision-making (Gaur & English, 2006; Rezal et al., 2015).  The Reducing Outpatient Antibiotic 
Resistance (ROAR) theory-based intervention is an evidence-based DNP project created to 
reinforce providers’ confidence by enhancing knowledge in their ability to manage ARIs without 
antibiotics.  The purpose of this DNP project was two-fold: to evaluate the outcome of an 
antibiotic stewardship program on urgent care providers’ antibiotic prescribing for ARIs, and to 
analyze providers’ awareness and beliefs regarding antibiotic use and resistance.   
Facilitators & Barriers 
There were a few factors that facilitated success of the DNP project which included 
effective communication of the vison and goals of the DNP project by the student investigator 
and support from DNP preceptor.  Challenges to the DNP project’s success included the 
providers’ resistance to change, feeling no benefit to themselves or to patient care, and sensing 
lack of time with patients to implement strategies.  Other barriers from management included the 
possibility of a decrease in patient satisfaction and taking time away from patients’ care.  The 
ROAR antibiotic stewardship program is sustainable because it is cost effective, simply 
formatted, easy to duplicate, generalizable to other outpatient facilities, and does not require a 
multidisciplinary team.   
Review of the Evidence 
PICOTS 
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The aim of this DNP project was to reinforce providers’ confidence by enhancing 
knowledge in their capability to manage ARIs without antibiotics.  In healthcare providers at 
urban urgent care centers, does an antibiotic stewardship program Reducing Outpatient 
Antibiotic Resistance compared to the current practice of no program reduce the prescribers' 
inappropriate use of antibiotics to treat ARIs and change healthcare providers’ knowledge and 
attitudes regarding antibiotic use and resistance within two months following the antibiotic 
stewardship program? 
Literature Search 
Relevant studies and guidelines were identified by searching Cochrane Database of 
Systematic Reviews, Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
National Guideline Clearinghouse, Ovid Medline, and PubMed databases for English language 
studies or guidelines published between 2007 and 2016.  Additional studies were obtained by 
reviewing research that was cited by the studies appearing in the preliminary search.  Selection 
criteria included human subjects of all ages, quantitative or qualitative, and all medical 
healthcare providers.  The search was expanded to include studies performed by countries other 
than the United States.  Interventions excluded delayed prescribing, restriction policies, financial 
incentives, point-of-care lab testing only, or patient education alone. The search strategy used 
Boolean operators for combinations of several keywords to identify relevant articles.  The 
keywords used in the search included the following: antibiotic or antimicrobial, resistance, acute 
or upper respiratory tract infection and illnesses, unnecessary or overuse or inappropriate use, 
ambulatory or outpatient or primary or urgent or emergency care, knowledge and attitude and 
practice (KAP) survey, healthcare provider, physician, nurse practitioner, stewardship, 
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intervention, prescribing behavior, decision making, evidence based guideline, computer 
decision support, academic detailing, audit, feedback, and communication skills. 
Evidence 
From this search, 31 studies were included in the integrative review (see Appendix A1 
and A2).  The studies were methodologically diverse: two evidence-based guidelines, there 
systematic review of quantitative studies, eleven quantitative randomized control trial, seven 
quantitative quasi-experimental, one quantitative cohort, one systematic review of quantitative 
and qualitative and mixed methods studies, three systematic reviews of qualitative studies, and 
three quantitative descriptive.  The 31 studies were separated into hierarchies of evidence level 
one through seven according to Melnyk and Fineout-Overholt (2015): five level I, 11 level II, 
seven level III, one level IV, four level V, three level VI, and zero level VII.     
Providers’ Knowledge, Attitude and Perceptions Regarding Antibiotic Use and Resistance 
According to the literature, most healthcare providers are aware of antibiotic resistance 
(Abbo et al., 2011; Abbo, Smith, Pereyra, Wyckoff, & Hooton, 2012; McCullough, Rathbone, 
Parekh, Hoffmann, & Del Mar 2015; Rezal et al., 2015) in which 98% deem it to be serious 
(McCullough et al., 2015), 89% believe it is a global problem (McCullough et al., 2015), and 
92% to 94% believe it is a national problem (Abbo et al., 2011, 2012; McCullough et al., 2015).  
Most, 94% to 98%, believe inappropriate use of antibiotics cause resistance (Abbo et al., 2011, 
2012; McCullough et al., 2015).  Providers were found to have inadequate knowledge about 
antibiotic prescribing (Abbo et al., 2011, 2012; Rezal et al., 2015), underestimate antibiotic 
resistance (Rezal et al., 2015), and some feel antibiotic resistance is a lower priority than their 
immediate patient needs (McCullough et al., 2015).  
Factors Influencing Provider Antibiotic Prescribing Behavior 
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The literature review revealed improper antibiotic prescribing has been linked to several 
indirect, extrinsic and intrinsic factors.  Indirect factors include provider uncertainty of diagnosis 
(Rezal et al., 2015; Rodrigues, Roque, Falcao, Figueiras, & Herdeiro, 2013) and lack of effective 
communication skills (Rodrigues et al., 2013).  Extrinsic factors include patient signs and 
symptoms present at time of visit (Lopez-Vazquez, Vazquez-Lago, & Figueiras, 2011; Rodrigues 
et al., 2013), serious or critically ill patient (Abbo et al., 2011, 2012; Rezal et al., 2015), and 
decreased patient visit time (Rodrigues et al., 2013; Sanchez, Roberts, Albert, Johnson, & Hicks, 
2014).  The most influential intrinsic factors included fear of missing infection (Abbo et al., 
2011, 2012), fear of patient complication (Lopez-Vazquez et al., 2011; Rodrigues et al., 2013; 
Sanchez et al., 2014), and provider complacency or perception that patient wants antibiotics 
(Lopez-Vazquez et al., 2011; Rezal et al., 2015; Rodrigues et al., 2013; Sanchez et al., 2014).  
Evidence-Based Guidelines 
Guidelines focused on ARIs among adults (Harris et al., 2016) and adults and children 
(Snellman et al., 2013) and assist providers in managing illnesses by detailing symptoms and 
differential diagnoses.  The guidelines help reduce unnecessary antibiotic use and improve first 
line antibiotic use for antibiotic appropriate infections by providing treatment recommendations 
and fostering provider-patient communication by providing tips and comfort measures to convey 
to patients.   
Antibiotic Stewardship Interventions  
Drekonja et al. (2015) performed a systematic review evaluating outpatient antibiotic 
stewardship programs and found that 40 of 55 interventions produced low- to moderate-strength 
evidence associated with improved antibiotic prescribing.  However, Ranji, Steinman, Shojania, 
and Gonzales (2008) performed an analysis among 30 ambulatory care stewardship intervention 
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trials, reporting a median decline in antibiotic use of 9.7%. which is equivalent to 25% relative 
reduction.  A systematic review by van der Velden et al. (2012) of 87 outpatient interventions 
focused on antibiotic use for ARIs and found that 60% of the interventions effectively enhanced 
antibiotic prescribing with a 11.6% overall antibiotic prescription reduction.  Two of the 
systematic reviews reported that multifaceted interventions using provider education are more 
effective in reducing antibiotic prescribing than single strategy interventions (Ranji, Steinman, 
Shojania, & Gonzales, 2008; van der Velden et al., 2012). 
Computer decision support system.  Interventions that embed algorithms within the 
electronic health record allow clinicians to review treatment strategies (CDC, 2015b).  Jenkins et 
al. (2013) showed an 11.2% relative reduction (p < .0001), and Gonzales et al. (2013) showed a 
13.3% absolute reduction (p = 0.014) in antibiotic prescribing for ARIs.  The use of broad-
spectrum antibiotics for ARIs decreased 16.5% in both children and adults (p < 0.05; Litvin, 
Ornstein, Wessell, Nemeth, & Nietert, 2013) and 16.6% in adults and 19.7% in children (p < 
0.0001; Mainous, Lambourne, & Nietert, 2013), and unnecessary antibiotic prescriptions reduced 
from 22% to 3.3% (p < 0.000; Rattinger et al., 2012). 
Academic detailing.  Interventions that provide detailed clinician education (CDC, 
2015c) revealed, in overall antibiotic prescribing rate, an absolute reduction of 13% in adults (p 
< 0.001; Grover et al., 2013), 10% in all ages (ratio of OR 2.60, 95% CI [1.23, 5.48]; Vinnard et 
al., 2013), and 4.2% in all ages (p = 0.02; Butler et al., 2012).  Regev-Yochay et al. (2012) 
showed a 40% decrease in antibiotic prescription rate (relative risk 0.76, 95% CI [0.75, .078]) 
and parent’s wish for antibiotics decreased 47%.  Gerber et al.’s study (2013) decreased broad-
spectrum antibiotic use 12.5% (p = 0.01). 
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Guidelines.  Interventions that include provision of evidence-based guidelines to 
healthcare providers to assist in clinical treatment showed a decrease in inappropriate antibiotic 
use of 9.8% (19.7% absolute reduction relative to control, p = 0.02) during the intervention 
period (Meeker et al., 2014) and antibiotic prescribing rates decreased 4.2% (p = 0.002) 
immediately after dissemination of the guidelines (Weiss, Blais, Fortin, Lantin, & Gaudet, 2011).  
Venekamp, Rovers, Verheij, Bonten, and Sachs (2012) found antibiotic prescription rate declined 
from 62 per 100 patient episodes to 56 per 100 patient episodes (p < 0.05).  
Feedback.   Interventions using feedback allow the healthcare provider to view a 
summary of their antibiotic prescribing rates over a specified period (CDC, 2015d).  Gjelstad et 
al. (2013) noted a reduction (33.2% to 31.8%) of antibiotic prescribing rates (adjusted OR 0.72, 
95% CI [0.61, 0.84]), yet their intervention included other methods.  Linder et al. (2012) found 
no difference in antibiotic prescribing rate between a control and intervention group, which was 
attributed to the lack of tool usage; but those who utilized the tool were less likely to prescribe 
antibiotics (p = 0.02).  Naughton, Feely, and Bennett (2009) saw a 2% reduction (p = 0.04) in 
antibiotic prescribing; however, the improvement returned to the pre-intervention rate 12 months 
after the intervention due to lack of participation and follow up. 
Communication skills training.  Interventions enhancing healthcare providers’ 
communication skills with patients to address patient expectations (Llor & Bjerrum, 2014).  
Little et al. (2013) showed a decrease of antibiotic prescribing by 9% (p < 0.0001), Altiner et al. 
(2007) showed a decrease of antibiotic rates by 60% six weeks following intervention (p < 
0.001) and remained at 40% reduction one year later (p = 0.028), and Légaré et al. (2012) 
revealed a 14% decrease in patients’ decision to use antibiotic after consultation (adjusted 
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relative risk 0.48, CI 95% [0.34, 0.68]) with patients more involved in decision-making (p < 
0.001). 
Theory 
The goals of Icek Ajzen’s theory of planned behavior (TPB) are to understand 
motivational influences on behavior and identify how and where to target strategies for changing 
behavior (Ajzen, 1991; Montaño & Kasprzyk, 2008).  An individual’s intention to carry out a 
behavior is a combination of one’s attitude towards the behavior, beliefs about whether other 
important individuals approve of the behavior, and perception of one’s capability to perform the 
behavior (Ajzen, 1985, 2002, 2012; Montaño & Kasprzyk, 2008).  Changing behavior will 
require changing the individual’s intentions by identifying the beliefs that support them (Ajzen, 
2012; Walker et al., 2001).   
The TPB has been found to be an appropriate theory to explain and predict behavior 
along with containing specific elements allowing the ability to predict the use of antibiotics to 
treat ARIs (Glanz et al., 2008; Eccles et al., 2007; Godin et al., 2008).  Butler et al. (2012) 
utilized an educational program based on the TPB and social cognitive theory in the United 
Kingdom resulting in a 4.2% reduction of antibiotics dispensed.  The Antibiotic Smart Use 
program in Thailand utilized a TPB theory-based antibiotic stewardship program resulting in an 
39% to 46% decrease in antibiotic use in primary care centers with a 12.9% decrease in 
antibiotic use for ARIs (Sumpradit et al., 2012; WHO, 2012).  The ROAR educational program 
was modeled after the TPB and designed to change provider antibiotic prescribing by addressing 
beliefs that influence behavior and intentions of performing the behavior (see Appendix B).  The 
multifaceted intervention includes five components designed to affect corresponding salient 
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beliefs: provider education, evidence-based practice guidelines, audit and feedback of providers’ 
rates of antibiotic prescribing, provider communication skills training, and patient education. 
Methods 
Institutional Review Board and Site Approval 
            The DNP research proposal was submitted and approved July 25, 2016 by the 
Institutional Review Board (IRB) at the study site hospital for research involving human subjects 
(see Appendix C).  The research was found to have minimal risk to provider participants and 
patients and required data collection from patient electronic medical records (EMR); hence, an 
expedited review by IRB was granted.  Site approval for the DNP project was obtained from the 
directors overseeing the urgent care centers (see Appendix D).   
Funding and Ethical Issues 
Funding for the DNP study was not obtained and the total cost for the project, $1128.00, 
was financed by the student investigator (see Appendix E).  Informed consent from each 
healthcare provider participant was obtained and included information about the research, 
potential risks and benefits associated with the research, and voluntary participation.  Data 
collected from the patient EMR did not include personal information, was coded to conform with 
Health Insurance Portability and Accountability Act (HIPAA), and was stored on an encrypted 
USB flash drive to limit breach in confidentiality.  All information from the EMR had a code 
assigned for the provider and patient and was kept independent of the data spreadsheet.  The 
provider questionnaire data was captured via an online secure database and de-identified as to 
not associate responses to an individual provider.  
Setting and Participants 
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The quasi-experimental study involved NP and MD providers and patient charts from a 
network of eight Missouri hospital-owned urgent care centers.  The centers are located within 
different urban and suburban regions across the large metropolitan area and serve children and 
adults of diverse racial and socioeconomic backgrounds.  The urgent care centers, staffed by 35 
NPs and 24 MDs, provide corporate health care and services to those seeking treatment for less 
critical or severe illnesses and injuries which require immediate care 365 days a year.  For the 
study, a convenience sample of 35 board-certified urgent care NPs and MDs, without any 
exclusion criteria, was expected to participate in the study.   
EBP Intervention 
Pre-intervention chart review.  Prior to the intervention, a baseline rate of incidence for 
antibiotic prescriptions was determined by performing a retrospective chart review of 150 charts 
of patients who sought care for ARIs at the urgent care centers from October 1, 2015 to 
December 31, 2015.  Information was collected by the student investigator from the patient EMR 
noting date of service, clinic site, provider and type, patient age, sex, past medical history, 
antibiotic allergies, duration of illness, diagnostic tests performed with results, antibiotic 
prescribed, and antibiotic name.   
Recruitment.  All NPs and MDs practicing at the eight urgent care centers were invited 
to participate in the study through recruitment flyers posted in the urgent care centers and sent 
via email (see Appendix F).  Within two weeks of the flyers being distributed, the student 
investigator followed up with providers to assess interest in the study (see Appendix G).  The 
providers were informed that they would be in the research study for a total of three months and 
would be required to complete a questionnaire and attend or view a one hour continuing 
education program.  In return, the providers would receive a $25 gift card and those who 
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attended the live session and filled out presentation evaluation (see Appendix H) would also 
receive 1.0 AMA PRA Category 1 CreditsTM.  The providers interested in voluntarily 
participating in the research study signed an informed consent and privacy authorization form 
(see Appendix I). 
Questionnaire.  One month prior to the intervention, utilizing the online secure REDCap 
(Vanderbilt University, 2016) database, the student investigator emailed a link to a questionnaire 
designed by Rodrigues et al. (2016) to assess knowledge and attitudes influencing antibiotic 
prescribing behavior and collect provider demographic data noting age, gender, type of provider, 
number of years practicing, years at an urgent care center, approximate number of patients seen 
per day, and average time spent with patients (see Appendix J).   
Intervention.  Clinical educational sessions were delivered by the student investigator 
onsite live twice, and a video presentation on YouTube via REDCap.  The presentation included 
objectives of the program; updates on problem and significance of antibiotic resistance and 
overuse of antibiotics; global, U.S., and Missouri antibiotic use; U.S. outpatient and the study’s 
urgent care centers antibiotic prescribing rates; acute respiratory infection facts; updates 
regarding current guidelines on acute respiratory infections; antibiotic stewardship initiative with 
goals of the study; and patient communication strategies (see Appendix K).  The providers were 
given a packet of information including a copy of the program slides, feedback from baseline 
chart audit, evidence-based practice guidelines for common ARIs from the California Medical 
Association’s Alliance Working for Antibiotic Resistance Education program (AWARE; 
California Medical Association, 2016; see Appendix L1), patient education brochures from the 
CDC Get Smart program (CDC, 2015e; see Appendix L2), and Michigan Antibiotic Resistance 
ROAR INTERVENTION 16 
Reduction Coalition (MARR) Clinical PEARLS (Michigan Antibiotic Resistance Reduction 
Coalition, 2004; see Appendix L3).   
Reminders.  Within two months after the intervention, participants were emailed on four 
separate occasions reminders of appropriate antibiotic use every 2 weeks (see Appendix M).   
Post-intervention chart review.  The student investigator performed a review of 156 
charts of patients who sought care for ARIs at the urgent care centers between November 1, 2016 
to December 31, 2016.  Post-intervention data included information from the patient EMR noting 
date of service, clinic site, provider and type, patient age, sex, past medical history, antibiotic 
allergies, duration of illness, diagnostic tests performed with results, antibiotic prescribed with 
antibiotic name.  The post-intervention results were compared to the baseline results to determine 
if there had been a decrease in healthcare provider antibiotic prescribing for ARIs (see Appendix 
N). 
Change Theory and EBP Model Assisting DNP Intervention 
Kurt Lewin’s change theory provides a process to facilitate change through phases of 
unfreezing, moving, and freezing (Lewin, 1947, 1958).  Unfreezing requires recognizing the 
need for change and seeking other ways to do things, moving requires creating new through 
teaching, and freezing entails reinforcing and sustaining the new change.  (Broud, Hatch, 
Corniea, Rice, & Mickelson, 2013).  The DNP project followed Lewin’s three phase process (see 
Appendix O).  Unfreezing was represented by presenting evidence regarding antibiotic resistance 
and need to change, assessing factors influencing antibiotic prescribing behavior, determining 
baseline antibiotic prescribing rates, and providing feedback to the providers.  Moving was 
addressed by presenting the ROAR educational program.  Freezing entailed providing post-
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intervention antibiotic prescribing rate results to providers and sending out reminders regarding 
judicious use of antibiotics. 
The Iowa Model of Evidence-Based Practice to Promote Quality Care (Titler et al., 
2001) was utilized as a framework to navigate change to reduce healthcare providers antibiotic 
prescribing for ARIs and allow integration of an antibiotic stewardship into clinical practice.  
The DNP project followed the Iowa model’s seven steps: (1) selecting an issue, (2) establishing a 
team, (3) retrieving relevant research evidence and related literature, (4) critiquing, grading and 
synthesizing the research evidence, (5) designing evidence-based practice guidelines, (6) 
implementing evidence-based practice as a pilot, and (7) evaluating the pilot, practice changes 
and disseminating results (Doody & Doody, 2011; Titler et al., 2001; see Appendix P).  
Employing a logic model that incorporated concepts from Titler’s Iowa Model provided an 
operational blueprint for the DNP project (see Appendix Q).  
Study design 
The quasi-experimental study, pre- and posttest design, was used to determine the effects 
of the ROAR antibiotic stewardship program on urgent care providers’ antibiotic prescribing for 
ARIs and assess providers’ knowledge and attitude concerning antibiotic use and resistance.  A 
retrospective baseline chart audit of patients with ARIs seen within the urgent care centers was 
completed to determine the antibiotic prescribing behavior of the healthcare providers which was 
compared to a prospective post-intervention chart audit.  A questionnaire developed by 
Rodrigues et al. (2016) was used to obtain provider demographic information and assess factors 
that influence healthcare providers’ prescribing behavior. 
Validity 
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To reduce threats to the internal and external validity of the study, specific measures were 
implemented to preserve the integrity of the data and degree of application to other settings.  
Aspects to promote internal validity included (a) time duration of two months between the 
intervention and obtaining post intervention chart data to diminish history and maturation 
variables, (b) the intervention was administered by the student investigator to diminish 
implementation variables, (c) a standardized case report spreadsheet to obtain information from 
EMR and a validated and reliable provider questionnaire to diminish instrumentation variables, 
(d) participants were not recruited by the medical director to decrease coercion bias, and (e) live 
seminar participants were provided continuing education units and all participants were provided 
a $25 gift card following the intervention to diminish attrition.  Aspects to promote external 
validity involved improving population validity by using study participants who were providers 
in outpatient facilities treating patients with common illnesses (ARIs) and lessening reactive 
arrangements by performing the study in a real-life setting.   
Outcome Measures 
The primary outcome measure of the DNP project was provider antibiotic prescribing 
rates for ARIs at baseline and post-intervention.  Secondary outcomes included differences in 
ARI antibiotic prescribing between MD and NP providers at baseline and post-intervention, and 
provider attitude and knowledge regarding antibiotic prescribing and resistance. 
Measurement Instruments 
Chart reviews.  A case report spreadsheet was utilized to collect data from EMR for 
encounters with the identified International Classification of Diseases, 10th Revision, Clinical 
Modification (ICD-10) codes (WHO, 2016) for ARIs (see Appendix R1).  To ensure accuracy of 
the data entered, double data entry method was used and data was cleaned to identify and correct 
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errors made during data entry.  Data obtained from medical records was like that of other studies 
(Gerber et al., 2013; Grover et al., 2013; Linder et al., 2010) to provide content validity.  Patients 
and providers were assigned a code and the code sheet was kept independent of the spreadsheet 
(see Appendix S).  Patient-level data included age, sex, past medical history and antibiotic 
allergies.  Visit-level data included date of service, practice site, clinician, clinician type (MD, 
NP), duration of illness, ICD-10 codes associated with encounter, diagnostic testing with results, 
and antibiotic prescriptions generated during encounter.  This data was used to determine 
baseline and post-intervention antibiotic prescribing rates and assess differences of antibiotic 
prescribing between provider types.  Pre- and post-intervention chart audit inclusion criteria 
consisted of patient encounters with at least one acute respiratory diagnosis on patients of all 
ages without prior visit to the center or other facilities for ARI during the previous 30 days.  
Exclusion criteria included encounters in which patients were provided delayed antibiotic 
prescription or other diagnosis which required antibiotic treatment.  ICD-10 codes were used to 
identify visit diagnoses (see Appendix R2 for study inclusion, Appendix R3 for exclusion).  
Systematic random sampling was performed utilizing the monthly patient log arranged by date 
and time of service.  From the log, the investigator selected and reviewed the first chart meeting 
study criteria from each day.  If no chart on a specific day met criteria, then the investigator 
proceeded to the next day.  At the end of the month, if there was a low number of charts meeting 
criteria, then the second chart meeting criteria from each day of the month was included in the 
data collection.   
KAP Survey.  Rodrigues et al. (2016) developed a questionnaire on healthcare provider’s 
attitude towards and knowledge of antibiotic prescribing and resistance to assess factors that 
influence antibiotic prescribing behavior in primary and hospital care providers (see Appendix 
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T).  The survey is a new instrument with limited use in studies.  Development of the tool 
consisted of a literature review to determine concepts of interest; pre-testing of the questionnaire 
to provide content validity; and evaluation by MDs, psychology and language experts to provide 
face validation.  Reliability was assessed by test-retest method, Cronbach’s alpha (! > 0.70) for 
internal consistency and interclass correlation coefficient (ICC > 0.4).  The self-administered, 26-
item questionnaire was designed to be effortlessly completed within five to ten minutes and was 
distributed to the participants via an emailed link to an online secure database.  Permission to use 
the questionnaire is not required because it is considered open access allowing unrestricted use 
under terms of the Creative Commons Attribution 4.0 International License.  A spreadsheet was 
used to collect provider demographic information consisting of age, gender, specialty (MD, NP), 
years of practice, years working in urgent care, number of patients seen per day, and average 
time spent with patients (see Appendix U).   
Quality of Data  
Power analysis was performed and determined that 150 patient charts are necessary to 
detect a significant change in antibiotic prescriptions written for ARIs.  Following Regev-Yochay 
et al. (2011), the student investigator used a medium effect (a 10% reduction in antibiotic 
prescribing rates), .05 alpha, and .8 power to determine an estimate of sample size.  Baseline and 
post-intervention data was used to determine change in provider antibiotic prescribing rates for 
ARIs and was compared to other studies (Grover et al., 2013; Vinnard et al., 2013).  Rodrigues et 
al.’s (2016) survey tool uses a visual analogue scale, and results were compared to the studies 
using questionnaires with Likert-style responses (Abbo et al., 2011, 2012; McCullough et al., 
2015).  
Analysis  
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Pre- and post-intervention antibiotic prescribing rates were based on proportion of visits 
for ARIs with a prescription for antibiotic which was calculated by dividing the number of ARI 
encounters in which an antibiotic was prescribed by the total number of ARIs.  Wilcoxon sign-
rank tests and McNemar tests were performed to detect differences between baseline and post-
intervention antibiotic prescribing rates for ARIs and to determine differences between MD and 
NP antibiotic prescribing rates for ARIs.  Chi-square tests for association were performed to 
determine association between type of provider and an antibiotic prescription for ARIs.  
Rodrigues et al.’s (2016) questionnaire was used to assess provider knowledge and attitude 
regarding antibiotic use and resistance.  The survey included 17 statements assessing fear, 
complacency (perception of patient expectations), ignorance (lack of knowledge), indifference 
(not feeling one way or another) and responsibility of others; and nine statements evaluating 
useful sources of knowledge.  Three statements evaluating beliefs were added by the investigator.  
Each response was measured with an unnumbered horizontal visual analogue scale scored from 
full disagreement (0%) to full agreement (100%).  Scores were recorded as a number from zero 
to 100, lower scores indicated greater disagreement and higher scores indicated greater 
agreement with the statement.  Mann-Whitney U tests were performed to determine differences 
in attitudes regarding antibiotic resistance and use between NPs and MDs, factors that influence 
antibiotic prescribing, and the most and least important sources of knowledge.  Exact p values 
and an alpha level of .05 were used for all statistical tests, and analysis was performed using 
IBM SPSS Statistics, version 24.0 (IBM Corp, 2016). 
Results 
Setting and Participants 
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The DNP project site was eight hospital-owned urgent care centers serving a large 
metropolitan area of Missouri during cold and flu season, October 2015 to December 2016.  
Provider demographic data was obtained from the internet-based questionnaire that was available 
for seven weeks between September to October 2016.  All the 59 NP and MD providers 
employed in the hospital-owned urgent care centers were invited to the study.  A total of 12 
providers consented to the study, and 8 (67%) completed both the educational session and the 
pre-questionnaire.  Study providers included 5 NPs (62.5%) and 3 MDs (37.5%) with an average 
of 11.25 years practicing (NP = 2.4 years, MD = 23.33 years) and 4.25 years practicing within an 
urgent care setting (NP = 2.4 years, MD = 7.33 years; see Appendix V).   
Intervention Course, Actual 
Pre-intervention groundwork included a 3-month baseline period of patient chart reviews 
from October to December 2015 that was conducted from August to September 2016.  A total of 
150 patient charts with ARI visits were reviewed pre-intervention with 60% seen by NPs and 
40% seen by MDs which included 28.7% male and 71.3% females, median age of 37.19 years 
(age range: 3 months - 89 years), and an average duration of illness of 5.48 days.  The top three 
diagnoses included pharyngitis (34.67%), URI (31.33%), and bronchitis (28%).  The intervention 
and post data collection spanned from end-September to December 2016.  A one hour clinician 
education session was delivered by the principal investigator on-site September 20 and 29, 2016 
and a video presentation was available on YouTube from mid-September to end-October 2016.  
Post-intervention patient chart reviews of November and December 2016 were conducted from 
mid-December 2016 to beginning January 2017.  A total of 156 patient charts with ARI visits 
were reviewed post-intervention with 64.1% seen by NPs and 35.9% seen by MDs which 
included 40.4% males and 59.6% females, median age of 38.5 years (age range: 1-86 years), and 
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an average duration of illness of 5.23 days.  The top three diagnoses included URI (45.52%), 
pharyngitis (26.28%), and bronchitis (24.36%; see Appendix W). 
Outcome of Antibiotic Prescribing Rates Pre- and Post-Intervention 
Overall antibiotic prescribing rates.  Of the eight study participants, the intervention 
elicited an improvement in antibiotic prescribing rate in five participants, whereas three 
participants saw no improvement (see Appendix X).  A Wilcoxon signed-rank test determined 
post-intervention antibiotic prescribing rates are equivalent to pre-intervention antibiotic 
prescribing rates, z = -1.890, p = .059.  An exact McNemar’s test determined the proportion of 
antibiotic prescribed decreased from pre-intervention value of 30% to 20% post-intervention, p 
= .078 (see Appendix Y). 
Outcome ARI Antibiotic Prescribing Rates Between NP and MD 
Pre-intervention type of provider.  A Chi-square test for association was conducted 
between type of provider (NP, MD) and antibiotic prescribed.  There was a statistically 
significant association between type of provider and antibiotic prescription for acute respiratory 
infection, "2(1) = 10.714, p = .001.  There was a weak positive association between type of 
provider and antibiotic prescription, # = .267, p = .001.  The odds ratio of preferring not 
prescribing antibiotic in NP vs. MD was 3.273 (95% CI, 1.585 to 6.756). 
Post-intervention type of provider.  A Chi-square test for association was conducted 
between type of provider (NP, MD) and antibiotic prescribed.  There was a statistically 
significant association between type of provider and antibiotic prescription for acute respiratory 
infection, "2(1) = 12.150, p = < .0005.  There was a weak positive association between type of 
provider and antibiotic prescription, # = .279, p = < .0005.  The odds ratio of preferring not 
prescribing antibiotic in NP vs. MD was 4.155 (95% CI, 1.801 to 9.583).  
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NP pre- and post-intervention.  A Wilcoxon signed-rank test determined post-
intervention antibiotic prescribing rates were equivalent to pre-intervention antibiotic prescribing 
rates, z = -1.460, p = .144.  An exact McNemar’s test was run and determined the proportion of 
antibiotic prescribed decreased from pre-intervention value of 20% to 12% post-intervention, p 
= .210 (see Appendix Y). 
MD pre- and post-intervention.  A Wilcoxon signed-rank test determined post-
intervention antibiotic prescribing rates were equivalent to pre-intervention antibiotic prescribing 
rates, z = -1.177, p = .239.  An exact McNemar’s test was run and determined the proportion of 
antibiotic prescribed decreased from pre-intervention value of 45% to 34% post-intervention, p 
= .327 (see Appendix Y). 
Outcome of Provider Questionnaire 
Attitudes.  Mann Whitney U tests were run to determine if there were differences in 
attitudes regarding antibiotic resistance and use between NPs and MDs.  Antibiotic resistance 
was believed to be a problem in their setting by 92.25% of all providers (89.6% NP, 96.67% 
MD), and the median attitude was not statistically significantly different between NPs (Mdn = 
98.00) and MDs (Mdn = 100.00), U = 5.50, z = -.640, p = .571.  Antibiotic resistance was 
believed to be a problem nationally by 96.38% of all providers (98% NP, 93.67% MD), and the 
median attitude was not statistically significantly different between NPs (Mdn = 98.00) and MDs 
(Mdn = 100.00), U = 6.00, z = -.458, p = .786.  Antibiotics were believed to be overused in their 
setting by 84.43% of all providers (83.4% NP, 86.67% MD), and the median attitude was not 
statistically significantly different between NPs (Mdn = 89.00) and MDs (Mdn = 85.00), U = 
7.50, z = .000, p = 1.0.  Antibiotics were believed to be overused nationally by 89.63% of all 
providers (90.4% NP, 88.33% MD), and the median attitude was not statistically significantly 
ROAR INTERVENTION 25 
different between NPs (Mdn = 99.00) and MDs (Mdn = 85.00), U = 6.50, z = -.302, p = .786 (see 
Appendix Z).   
Factors influencing prescribing.  Mann Whitney U tests were run to determine factors 
that influenced antibiotic prescribing.  The most indifference attitude was prescribing an 
antibiotic even when known that not indicated but no time to explain the reason to the patient 
(Mdn = 21.50), U = .000, z = -2.236, p = .036.  The greatest fear was due to inability to conduct 
patient follow up (Mdn = 51.00), U = 3.0, z = -1.342, p = .250.  The greatest complacency issue 
was providing an antibiotic to maintain patient trust (Mdn = 25.00), U = 5.0, z = -.745, p = .571.  
The highest lack of knowledge was thinking there is a need to wait for microbiology results 
before treating an infectious disease (Mdn = 49.50), U = 4.0, z = -1.043, p = .393. Providers felt 
it is the responsibility of others to closely control dispensing antibiotics without a prescription 
(Mdn = 96.00), U = 7.0, z = -.153, p = 1.0 (see Appendix Z). 
Sources of knowledge.  Mann Whitney U tests were run to determine the most important 
source of knowledge as CEUs (Mdn = 85.00), U = 7.0, z = -.150, p = 1.0 and least important 
source as the internet (Mdn = 50.00), U = 5.0, z = -.750, p = .571 (see Appendix Z). 
Discussion 
Successes, Most Important 
The main goal of the study, which was to decrease healthcare providers prescribing 
antibiotics for ARIs, was achieved within several different aspects: prescribing rate and 
percentage of antibiotics associated with different diagnoses.  Although not statistically 
significant, there was an overall decrease in antibiotic prescribing for ARIs by all providers from 
30% baseline (20% NP, 45% MD) to 20% post-intervention (11% NP, 33.93% MD), which 
equates to a 33.3% relative reduction and a 10% absolute reduction (NP = 45% relative 
ROAR INTERVENTION 26 
reduction, 9% absolute reduction; MD = 24.6% relative reduction, 11.07% absolute reduction).  
Of the eight providers, three (2 NP, 1MD) did not write for any antibiotics post-intervention.   
The number of different antibiotics prescribed decreased post-intervention: Amoxicillin 
decreased 70.47%; Augmentin decreased 68%; and Keflex, Ceftin, Penicillin and Avelox 
decreased to 0% representing a 100% decrease.  The percentage of antibiotics prescribed for 
diagnoses also decreased post-intervention, antibiotics for bronchitis decreased 4.48%, 
pharyngitis decreased 72.04%, and URI decreased 56.67% (see Appendix W). 
Study Strengths 
This study had several strengths.  Within the study, the survey was anonymous to reduce 
socially desirable response and was also web-based to allow greater accessibility.  It was a 
challenge in obtaining study participants at onset and IRB agreed to amend the study allowing 
the educational seminar intervention to be done by video on-line or live sessions.  Within the 
setting, charts were available via EMR allowing accessibility, a randomized process of obtaining 
charts to review was utilized to limit sample bias, and the study gathered provider and patient 
data from an expansive geographical area within a large metropolitan area of Missouri.   
Results Compared to Evidence in the Literature 
There are numerous studies with various designs targeted at decreasing outpatient 
antibiotic prescribing for ARIs.  Studies which utilized academic detailing interventions similar 
to this study reported decrease in antibiotic prescribing rate from 69% to 56% (19% relative 
reduction, 13% absolute reduction, Grover et al, 2013) and from 43% to 33% (23.26% relative 
reduction, 10% absolute reduction, Vinnard et al, 2013).  This current study revealed an overall 
decrease in antibiotic prescribing for ARIs by all providers from 30% baseline to 20% post-
intervention which equates to a 33.3% relative reduction and a 10% absolute reduction.   
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Within the literature review, no studies were found that compared the antibiotic 
prescribing rates between different providers (NP vs. MD).  This study did reveal that NPs 
decreased antibiotic prescribing rate from 20% to 11% (36% relative reduction, 9% absolute 
reduction) and MDs decreased antibiotic prescribing rate from 45% to 33.93% (24.6% relative 
reduction, 11.07% absolute reduction).  There was a weak positive association between type of 
provider and antibiotic prescription pre- and post-intervention in which the odds ratio of NPs 
preferring not to prescribe an antibiotic was 3.273 (pre-intervention) and 4.155 (post-
intervention) times more than MDs.   
A 2015 systematic review included 57 studies of 11,593 clinicians’ perceptions about 
antibiotic use and resistance, and the study revealed that 92% believe antibiotic resistance is a 
problem nationally whereas 77% believe it to be a problem locally (McCullough et al., 2015).  In 
contrast, 96.38% of the providers in this study believe antibiotic resistance to be a problem 
nationally and 92.25% believe it to be a problem locally.  In previous studies, MDs believe 
antibiotics are overused locally 76% and nationally 94% (Abbo, et al., 2011), and NPs believe 
antibiotics are overused locally 54% and nationally 93% (Abbo et al., 2012) which contrasts to 
this study findings that MDs believe antibiotics are overused locally 86.67% and nationally 
88.33% and NPs believe antibiotics are overused locally 83.4% and nationally 90.4%.   
Limitations 
Internal validity effects.  This study had several limiting factors.  First, with the data 
obtained, the investigator is not able to determine which element(s), educational seminar or audit 
and feedback or email reminders, decreased antibiotic prescribing.  Second, regarding 
instrumentation, it is unknown if those providers who chose to view the video presentation 
watched it completely, and although the KAP questionnaire was validated, it was developed in 
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2016 and had not reportedly been used by other studies.  Third, a few of the study providers were 
already low antibiotic prescribers at baseline.  Fourth, the KAP questionnaire responses and 
prescribing behavior can be influenced because the provider knowingly is participating in a study 
(Hawthorne effect).  Fifth, participant selection bias might have occurred via personal 
recruitment by the principal investigator.  
External validity effects.  There were several factors that can affect generalizability.  
First, generalizability of results can be negatively affected by the small number of study 
participants and charts reviewed.  Second, the intervention was implemented within a hospital-
owned system of urgent care centers, excluding the hospital emergency department and primary 
care providers associated with the network.  Third, the study’s limited length of observation 
period following the intervention, November to December 2016, is not a substantial duration of 
time to measure sustainability of decreased antibiotic prescribing. 
Sustainability of effects and plans to maintain effects.  Sustainability of the DNP 
project can be a challenge because of providers’ reluctance to change their prescribing 
behaviors.  Nevertheless, antibiotic stewardship sustainability will require support from 
management and administrators, implementing the program into new provider orientation, and 
adding it to the policies and procedures guidelines.  Key facilitators should perform annual chart 
audit and individualized provider feedback of antibiotic prescribing to give insight on their 
performance in accordance with local and national antibiotic prescribing rates.  Once reminders 
or education are stopped, one would expect the antibiotic prescribing rates to slowly increase 
overtime.  Therefore, to maintain low prescribing rates, quarterly reminders with yearly classes 
are recommended to stress the importance of antibiotic stewardship. 
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Efforts to minimize the study limitations.  The study was purposefully conducted at the 
end of the year to obtain data during cold/flu season because studies have shown increase in 
antibiotic prescribing during winter months (Suda, Hicks, Roberts, Hunkler & Taylor, 2014).  To 
increase the number of study participants, recruitment was done via email, personal visits to 
centers, and during one provider meeting.  Although personal recruitment could have added to 
selection bias, it was determined that the medical director would not encourage participation to 
decrease coercion bias.  Also, the decision was made to perform two live educational sessions in 
addition to video presentation and offering continuing medical education credit to those who 
attended the live session to increase study participation.  Finally, the KAP questionnaire was 
web-based to provide easy access for participants and done prior to education sessions to elicit 
genuine attitudes regarding antibiotic resistance and use.  
Interpretation 
Expected and actual outcomes.  From this study, there was an expectation of all 
providers to decrease antibiotic prescribing rates, especially in those who had a higher baseline 
prescribing rate, and to obtain statistically significant results.  Unfortunately, this was not the 
case and might be due to reluctance of the providers to change prescribing behavior, the 
investigator not providing clinician-specific prescribing rate feedback, and the low number of 
study participants and charts reviewed.  Unexpectedly, there were a few providers who had a low 
baseline antibiotic prescribing rate that increased post-intervention.  This could be possibly 
attributed to patients diagnosed with conditions in which there is a higher antibiotic prescribing 
rate such as bronchitis or provider uncertainty with cause of illness being viral in nature.  
However, three providers successfully decreased their antibiotic prescribing rate to 0% post-
intervention.   
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Intervention’s effectiveness.  The study’s multifaceted intervention was designed to 
include concepts of prior successful academic detailing studies focused on decreasing outpatient 
antibiotic prescribing and to target and affect provider beliefs which is essential in changing 
prescribing behavior.  Rather than the intervention performed by a team of people who have 
different personalities and teaching styles, the intervention was performed by the principal 
investigator, a colleague to study participants.  Because of the feedback obtained and interaction 
among the principal investigator and participants, it is most likely that small group settings of up 
to 20 outpatient, emergency department or urgent care providers would be effective in generating 
dialogue and affecting antibiotic prescribing practices.   
Intervention revision.  There are a few modifications that can achieve greater effects.  
First, the KAP questionnaire should be distributed months prior to the intervention to determine 
factors that influence antibiotic prescribing and focus education based on those findings.  
Second, because the intervention is multifaceted, additional elements such as addressing patient 
education through education posters and brochures in waiting and exam rooms, and providing 
clinician specific along with system wide antibiotic prescribing rates feedback to each provider 
may enhance improvement in appropriate prescribing.  And last, the charting is done via EMR, 
and a program can be installed to provide pop-up reminders and alerts when choosing antibiotic 
treatment with associated diagnoses.  
Expected and actual impact to health system, costs, and policy.  This EBP 
intervention can impact healthcare providers’ knowledge regarding antibiotic resistance and use 
while decreasing antibiotic prescribing habits for those patients presenting with ARIs.  The 
intervention will also bring antibiotic stewardship to the forefront of quality healthcare allowing 
increased health benefits through preserving antibiotic effectiveness, decreasing antibiotic 
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resistant infections, and reducing healthcare costs associated with this global public health 
problem.  Antibiotic stewardship programs were initially started in hospital settings; however, 
studies have revealed in the United States among the many outpatient prescription medications 
that few are more widely prescribed than antibiotics (Gerber et al., 2013; Lee et al., 2014).  
Utilizing the study intervention in urgent care centers, emergency departments, and primary care 
offices will effectively expand antibiotic stewardship to the ambulatory setting to comply with 
the National Action Plan for Combating Antibiotic-Resistant Bacteria in reducing outpatient 
inappropriate antibiotic use by 50% by 2020 (The White House, 2015). 
Over the course of the intervention, costs changed in which the cost of investigator and 
CME accreditation were removed, CDC brochures were obtained free of charge, the number of 
provider gift cards was reduced, items that needed to be printed was increased although it was 
$205 less than projected printing cost, catered food to educational sessions remained the same, 
and costs for USB card and dissemination of the project at the Advanced Practice Nurses of 
Ozarks conference was added.  Grant funding was not obtained; therefore, every effort was used 
to limit costs.  Total direct and indirect costs incurred totaled $1128, which was $899 less than 
the projected budget of $2027.  Economic sustainability can be achieved with this simple, low-
cost intervention over numerous years by removing monetary incentives and replacing with 
continuing educational credits, integrating the program into provider orientation, emailing 
quarterly reminders, and hosting yearly classes within the hospital system.   
Conclusion 
Practical Usefulness of Intervention 
Interventions that are patient-centered; easily implemented into practice; and allow 
healthcare providers to reflect on practice, decrease doubt about treatment, and learn appropriate 
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prescribing will foster change in antibiotic prescribing behavior (Tonkin-Crine, Yardley, & Little, 
2011).  Healthcare providers must adhere to antibiotic prescribing measures to preserve antibiotic 
effectiveness and decrease antibiotic resistance, and educating healthcare providers is a major 
step in changing antibiotic practices.  The development and utilization of an outpatient antibiotic 
stewardship program will promote judicious use of antibiotics for ARIs by healthcare providers 
within urgent care, emergency department, and primary care facilities.   
Further Study of Intervention and Dissemination 
Implementing the antibiotic stewardship intervention within the hospital system fosters 
continual measurement of the rate of antibiotic prescription incidence associated with ARIs and 
potentially determines broad-spectrum antibiotic rates for ARIs and patient return visit (≤ 30 
days from incident visit) rates.  The ROAR DNP project proposal was presented to other 
advanced practice nurses via poster presentation November 11, 2016 at the Advanced Practice 
Nurses of the Ozarks conference in Branson, Missouri.  A poster of the completed ROAR DNP 
study was presented at the University of Missouri – Kansas City’s Health Sciences Student 
Research Summit April 26, 2017.  Both poster presentations allowed sharing of antibiotic 
stewardship principles with other providers, professors, and students and align with national and 
local efforts to improve antibiotic use within outpatient and hospital settings.  An executive 
summary was written and distributed to the study participants, urgent care management, hospital 
administration, and IRB.  A manuscript was written and submitted to the Journal of Doctoral 
Nursing Practice to foster healthcare provider knowledge on antibiotic stewardship.   
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Appendix A1 
Definition of Terms 
Academic detailing interventions provide detailed clinician education (CDC, 2015c). 
Antibiotic resistance is a phenomenon that happens when an antibiotic loses its ability to 
successfully eradicate bacterial growth (Institute of Medicine [IOM], 2010). 
Antibiotic stewardship is an interventional program for healthcare providers to enhance 
knowledge of antibiotic resistance and promote principles of responsible antibiotic use to 
preserve antibiotic effectiveness and decrease resistance (CDC, 2013; Gangat & Hsu, 2015).   
Communication skills interventions are geared towards improving healthcare providers’ 
communication with patients informing them about their clinical condition and non-use of 
antibiotics for self-limiting conditions (Llor & Bjerrum, 2014). 
Computer decision support system interventions embed algorithms within the electronic 
health record allowing clinicians to review treatment strategies (CDC, 2015b).   
Feedback interventions use feedback to allow the healthcare provider to view a summary of 
their antibiotic prescribing rates over a specified period (CDC, 2015d). 
Guidelines interventions include provision of evidence-based guidelines to healthcare providers 
to assist in clinical treatment. 
Knowledge, Attitude and Perception (KAP) surveys are focused evaluations that analyze the 
extent of awareness about, beliefs towards, and practice in relation to health-related concepts 
(Launiala, 2009) uncovering misconceptions and potential barriers to devise interventions based 
on knowledge gaps, misguided beliefs and erroneous attitudes (Launiala, 2009; SPRING, 2014; 
Unite for Sight, 2010). 
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Synthesis of Evidence Table 
First Author, 
(Year), Title, 
Journal 
Purpose & 
Study 
Timeframe 
Research 
Design1, 
Evidence Level 
(1-7)2, 
Variables3 
Setting, 
Sample4a (size), 
Sample Type, 
& Place 
Measures, Reliability (if reported) & Results  Strengths, 
Limitations & 
Usefulness 
Knowledge, Attitude, and Practices Among Healthcare Providers Regarding Antibiotic Use and Stewardship 
Abbo (2011). 
Faculty and 
resident 
physicians’ 
attitudes, 
perceptions, and 
knowledge about 
antimicrobial use 
and resistance. 
Infection Control 
and Hospital 
Epidemiology 
Assess 
attitudes, 
perceptions, & 
knowledge 
about ABX use 
& resistance. 
 
Aug 3 to Sept 
14, 2009 
Quantitative, 
descriptive 
study (survey) 
Level 6 
Teaching 
Hospital 
 
609 clinicians 
(MD: 329, 
Resident: 280) 
 
Voluntary, 
anonymous 
 
Florida, USA 
Influential factors affecting ABX prescribing: 
missing infection (p =.001), critically ill or 
immune-compromised patient (p < .001). 
Highly aware of ABX resistance & concerned. 
ABX overused nationally (94%) & locally 
(76%), inappropriate use causes resistance (97%) 
 
13% believed they themselves (62% others) 
overprescribe ABX. 
 
ABX knowledge test mean score 67%. 
Strengths: 
Anonymous 
Limitations:  50.75% 
response rate, 
questionnaire not 
externally validated, 
single institution, 
selection bias, surveys 
may be gaps between 
what is said/done. 
MDs only. 
Usefulness: 
Demonstrates areas to 
target w/ interventions. 
      
Abbo (2012). 
Nurse 
Practitioners’ 
attitude, 
perceptions, and 
knowledge about 
antimicrobial 
stewardship. The 
Assess 
attitudes, 
perceptions, & 
knowledge 
about ABX 
use, resistance, 
& stewardship. 
 
Quantitative, 
descriptive 
study (survey) 
 
Level 6 
Teaching 
Hospital 
 
58 Nurse 
Practitioners 
 
Voluntary, 
anonymous 
Influential factors affecting ABX prescribing: 
missing infection (67%) or critically ill or 
immune-compromised patient (89%) 
often/always affect decision to select ABX. 
Highly aware of ABX resistance & concerned. 
60% start with broad-spectrum ABX. 
ABX overused nationally (93%), locally (54%), 
inappropriate use causes resistance (98%) 
Strengths: 
Anonymous, assessed 
NPs 
Limitations: Low 
response rate (43%), 
small study, selection 
bias, questionnaire not 
externally validated, 
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Journal for 
Nurse 
Practitioners 
Aug 23 to Nov 
4, 2009 
Florida, USA 4% believed they themselves (6% others) 
overprescribe ABX. 
 
66% not familiar with ABX stewardship & only 
17% perceived as useful. 
 
ABX knowledge test mean score 69%. 
single institution, 
surveys may be gaps 
between what is 
said/done. 
Usefulness:  
Demonstrates areas to 
target w/ interventions. 
      
Sanchez (2014). 
Effects of 
knowledge, 
attitudes, and 
practices of 
primary care 
providers on 
antibiotic 
selection, United 
States. Emerging 
Infectious 
Diseases 
Explore 
knowledge, 
attitudes, & 
self-reported 
practices 
regarding ABX 
therapy & 
assess factor 
influencing 
ABX choice 
 
May 2013 
Quantitative, 
descriptive 
study (open-
ended phone 
interview) 
Level 6 
Primary care  
 
36 providers 
(MD: 27, NP: 5, 
PA: 4) 
 
Purposive 
sampling with 
certain 
exclusion 
criteria 
 
USA 
Common perceptions for inappropriate ABX 
prescribing: patient pressure (perceive they 
expect ABX), fear of complications, patient 
satisfaction, & decrease in visit length.  
Aware of guidelines yet not always comply, 
believe broad-spectrum ABX better cure rate. 
 
Believe changing behavior is difficult & 
reluctant to change because been doing that way 
for years. 
Strengths: 
Open-ended interview 
Limitations: Small 
study sample, not 
generalizable because 
lack of external 
validity, selection bias, 
with surveys may be 
considerable gaps 
between what is said 
and what is done 
Usefulness:  
Demonstrates areas to 
target w/ interventions. 
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First Author, 
(Year), Title, 
Journal 
Purpose & 
Search 
Timeframe 
Research 
Design1, 
Evidence Level 
(1-7)2, 
Database 
Number of 
Studies & 
Place 
Setting, 
Sample4a 
(size), & 
Sample Type 
Analysis Used & Results Strengths, 
Limitations & 
Usefulness 
Systematic Review:  Knowledge, Attitude, and Practices Among Healthcare Providers Regarding Antibiotic Use and Stewardship 
McCullough 
(2015). Not in 
my backyard: a 
systematic 
review of 
clinicians’ 
knowledge and 
beliefs about 
antibiotic 
resistance. 
Journal of 
Antimicrobial 
Chemotherapy 
Review 
knowledge & 
beliefs about 
significance & 
causes of ABX 
resistance & 
plans to 
reduce. 
 
Inception until 
3rd week July 
2014 
Systematic 
review 
quantitative, 
qualitative & 
mixed method 
studies 
Level 5 
 
Searched 
MEDLINE, 
EMBASE, 
PsycINFO, 
CINAHL 
 
57 studies 
Quant: 38 
Qual: 14 
Mix: 5 
 
N. America 
(39%), Europe 
(26%), Asia 
(19%), S. 
America, 
Africa, 
Australia (each 
5%) 
Hospital, 
primary care, 
university, 
mixed 
 
11,593 
clinicians: 
MD (63%), 
nurses (4%), 
pharmacists 
(5%), dentists 
(5%), mixed 
(23%) 
 
Sampling:  
Convenience, 
purposive, 
random, 
snowball, not 
reported 
Median, IQR & range 
calculated for % of participants 
agreeing with each category.  
 
Quant data synthesis: 
ABX resistance problem 
globally (89%), nationally 
(92%), locally (77%), & in 
their practice (67%).  
Causes of resistance: 
inappropriate use (94%), 
broad-spectrum use (95%), 
patient non-adherence to ABX 
(90%). 
(69%) heard of ABX resistance 
To reduce resistance, need to 
decrease ABX use (96%) & 
need educational interventions 
(90%). 
Qual data synthesis: some 
don’t believe ABX resistance 
serious problem or believed 
out of their control; ABX 
resistance lower priority than 
immediate patient needs. 
Strengths: 
Comprehensive 
search, qualitative data 
allowed understanding 
of findings. 
Limitations: diverse 
quantitative outcomes 
& various study sizes, 
low to moderate 
response rates, 
question validity not 
known, possible 
response bias (answer 
in way viewed 
favorable). 
Usefulness:   
Demonstrates areas 
where interventions 
could be targeted. 
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First Author, 
(Year), Title, 
Journal 
Purpose & 
Search 
Timeframe 
Research 
Design1, 
Evidence Level 
(1-7)2, 
Database 
Number of 
Studies & 
Place 
Clinical 
Condition5, 
Provider6 
Surveyed 
Measures, Analysis Used (if 
reported), & Results 
Strengths, 
Limitations & 
Usefulness 
Systematic Reviews: Understanding Healthcare Provider Antibiotic Prescribing Behavior 
Lopez-Vazquez 
(2011). 
Misprescription 
of antibiotics in 
primary care: A 
critical 
systematic 
review of its 
determinants. 
Journal of 
Evaluation in 
Clinical Practice 
Identify 
factors, 
attitudes, & 
knowledge 
related to ABX 
over 
prescribing. 
 
Jan 1987 to 
Feb 2008 
Systematic 
review 
qualitative 
studies 
Level 5 
 
Searched 
MEDLINE-
PubMED, 
EMBASE, 
other references 
cited  
46 papers 
 
USA: 16, UK: 
4, Netherlands: 
4, Australia: 3, 
& 16 other 
countries 
39 studies: 
respiratory 
infections 
 
7 studies: no 
condition or 
other 
 
MD only 
Factors associated with ABX 
prescribing: 
Socio-demographic & personal 
not much influence. 
MD attitude – perceived 
patient expectation & fear of 
complications. 
Patient characteristics – 1 or 
more pt sign/symptoms, # 
patients seen daily. 
Socio-demographic & personal 
factors exhibited not much 
influence. Complacency 
(perceived patient 
expectations), fear (possible 
patient complications), one or 
more patient signs/symptoms, 
number of patients seen daily -
associated with ABX 
prescribing. 
Strengths: Reviewed 
multiple studies. 
Limitations: Evaluated 
MD views only. 
Usefulness:  Guidance 
in determining key 
concepts to focus on 
when developing 
interventions. 
       
Rodrigues 
(2013). 
Understanding 
physician antibiotic 
Explore 
physicians’ 
perceptions of 
factors 
Systematic 
review 
qualitative 
studies 
35 papers 
Qualitative: 26 
Mixed: 9 
 
12 studies: 
respiratory 
infections 
Factors associated with ABX 
prescribing: 
Most influential on ABX 
prescribing was complacency 
Strengths: Looked at 
MD & other providers. 
Limitations: Small 
numbers of 
ROAR INTERVENTION 53 
!! !
prescribing 
behaviour: A 
systematic review 
of qualitative 
studies. 
International 
Journal of 
Antimicrobial 
Agents 
influencing 
ABX 
prescribing. 
 
Jan 1987 to 
Dec 2011 
Level 5 
 
Searched 
MEDLINE, 
PubMED 
 
5 different 
continents, 
mainly Europe 
(18) & USA 
(10) 
15 studies: 
didn't id 
conditions 
8 studies: other 
conditions 
MD, nurses, 
other 
healthcare 
providers 
or fear. Extrinsic factors - 
patient sign/symptom & time 
pressures or guidelines 
implemented.  Indirect factors- 
communication skills & 
diagnostic uncertainty. 
participants, included 
only heterogeneous 
studies making 
susceptible to bias. 
Usefulness:  determine 
key concepts to focus 
on when developing 
interventions. 
       
Rezal (2015). 
Physicians’ 
knowledge, 
perceptions and 
behaviour 
towards 
antibiotic 
prescribing: A 
systematic 
review of the 
literature. Expert 
Review of Anti-
infective Therapy 
Review 
knowledge, 
perceptions, & 
prescribing 
behavior 
regarding ABX 
prescribing. 
 
1990 to 2014 
Systematic 
review 
qualitative 
studies 
Level 5 
 
Searched 
Scopus, 
PubMed, ISI 
Web of 
Knowledge, 
Proquest, 
ScienceDirect, 
Google Scholar, 
& 
bibliographies 
of retrieved 
studies 
 
19 articles 
 
11 developed 
countries (USA: 
4), 8 developing 
countries 
Majority of 
studies 
evaluated 
respiratory 
conditions 
 
MD only 
MDs still with inadequate 
knowledge & misconceptions. 
Underestimate ABX resistance. 
Factors associated with 
increased ABX prescribing: 
patient expectations, acuity & 
duration of illness, uncertainty 
of diagnosis, potential of 
losing patients. 
Strengths: Providers 
from different 
specialties interested 
in learning more & 
improving ABX 
prescribing, also want 
feedback on ABX 
prescribing, 
studies from 
developed & 
developing countries 
Limitations: results 
related to MDs only.  
Usefulness: determine 
key concepts to focus 
on when developing 
interventions. 
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Institute 
(Year) 
Purpose Research 
Design1, 
Evidence Level 
(1-7)2 
Clinical Condition5, (Author) 
Strengths & Limitations 
Evidence-Based Guidelines 
Institute for 
Clinical Systems 
Improvement 
(2013). 
Diagnosis and 
management 
Evidence Based 
Practice 
Guidelines 
Level 1 
Respiratory illness in children and adult (Snellman, et al): 
Strep pharyngitis, noninfectious rhinitis, bacterial sinusitis, viral upper-respiratory infection 
 
Strengths: Multiple diagnoses, interactive links on algorithms, all ages, patient information. 
Limitations: Links only active on computer. 
     
American College 
of Physicians & 
Centers for 
Disease Control 
Prevention 
(2016). 
Diagnosis and 
management 
Evidence Based 
Practice 
Guidelines 
Level 1 
Acute respiratory infections in adults (Harris, Hicks & Qaseem): 
Acute bronchitis, pharyngitis, acute rhinosinusitis, common cold 
 
Strengths: Easy to read, multiple diagnoses, care advice, management strategies, 
determinants of bacterial infection, tips on appropriate ABX use 
Limitations: Limited patient information, only adults. 
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First Author, 
(Year), Title, 
Journal 
Purpose & 
Search 
Timeframe 
Research 
Design1, 
Evidence Level 
(1-7)2, 
Database 
Number of 
Studies, Type 
of Studies, & 
Place 
Clinical 
Condition5 
Measures, Analysis Used & 
Results 
Strengths, 
Limitations & 
Usefulness 
Systematic Reviews: Interventions 
Ranji (2008). 
Interventions to 
reduce 
unnecessary 
antibiotic 
prescribing: A 
systematic 
review and 
quantitative 
analysis. Medical 
Care 
Evaluate effect 
of 
interventions 
to reduce 
unnecessary 
ABX 
prescribing. 
 
(Jan 1996 to 
March 2007) 
Systematic 
review 
quantitative 
studies 
Level 1 
 
Searched 
Cochrane 
Collaboration 
Effective 
Practice & 
Organization of 
Care database, 
MEDLINE, & 
bibliographies 
of included 
articles 
 
 
 
43 studies 
reporting 55 
separate trials  
 
24 randomized 
control trials, 
26 controlled 
before-after 
trials, 
5 quasi-
randomized 
control trials 
 
Most studies 
conducted in 
USA & Europe 
but also 
included 15 
other countries 
38 studies: 
ARIs 
 
8 studies: 
didn't id 
disease 
 
4 studies: acute 
diarrhea 
Calculated median effect size 
of studies then used 
nonparametric statistics to 
compare trials with & without 
characteristics of interest.  
 
30 eligible trials, median 
reduction in ABX use was 
9.7% (interquartile range 6.6-
13.7%), equal to relative 
reduction of 25%. No 
individual or combo of 
interventions significantly 
more effective than other 
(p=0.85). Active education 
more effective than passive 
education (p=0.096). Savings 
at population level ranging 
from 17 to 117 prescriptions 
per 1000 person-years. 
Strengths: All studies 
outpatient & majority 
involved ARIs. 
Evaluated fair amount 
of studies. 54% of 
studies able to perform 
quantitative analysis 
on synthesized data. 
Limitations: No formal 
meta-analysis since 
many did not report 
exact numbers. Small 
# trials each group = 
lack of statistical 
power to evaluate 
effectiveness of 
intervention. Effects of 
interventions may not 
be generalizable.   
Usefulness: Active 
clinician education 
interventions are 
effective at reducing 
ABX use. 
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van der Velden 
(2012). 
Effectiveness of 
physician-
targeted 
interventions to 
improve 
antibiotic use for 
respiratory tract 
infections. 
British Journal of 
General Practice 
Assess 
effectiveness 
of clinician-
targeted 
interventions 
to improve 
ABX 
prescribing for 
ARTIs in 
primary care 
and identify 
successful 
features. 
 
(Jan 1990 to 
July 2009) 
Systematic 
review 
quantitative 
studies 
Level 1 
 
Searched 
MEDLINE, 
EMBASE, & 
Cochrane 
Library 
 
 
58 studies 
describing 87 
interventions 
 
41% were 
controlled 
before after 
design, 
29% RCT, 
remaining RCTs 
without baseline 
measurement or 
interrupted time 
series-like 
design 
All studies 
addressed 
ARIs 
 
 
Association between 
effectiveness & intervention 
features analyzed in logistic 
regression.  
 
87 Interventions: educational 
material for provider, 
educational meeting, audit & 
feedback. 
 
60% (52) of interventions 
significantly improved ABX 
prescribing, overall ABX 
prescription reduced by 11.6%. 
Multiple interventions with 
educational material for 
provider effective (adjusted 
OR 6.5; 95% CI 1.9-22).   
Strengths: Studies 
outpatient & involved 
ARIs. Evaluated fair 
amount of studies. 
Limitations: Broad 
variety of designs 
decreases overall 
quality, differences in 
outcome measures 
cannot be compared.  
Usefulness: 
Multifaceted 
interventions with 
provider education, 
communication 
training, & lab testing 
effective in reducing 
ABX prescribing. 
       
Drekonja (2015). 
Antimicrobial 
stewardship in 
outpatient 
settings: A 
systematic 
review. Infection 
Control and 
Hospital 
Epidemiology 
Evaluate effect 
of outpatient 
ABX 
stewardship 
programs. 
 
(Jan 2000 to 
Nov 2013) 
Systematic 
review 
quantitative 
studies 
Level 1 
 
Searched 
MEDLINE, 
EMBASE, & 
Cochrane 
Library 
 
 
50 studies: 
17 RCT, 
18 cluster RCT,  
3 controlled 
clinical trials,  
6 controlled 
before/after 
trials, 
6 interrupted 
times series 
studies 
 
Studies 
conducted in 
58% studies 
reporting on 
respiratory 
tract infections 
 
34% studies 
reporting 
multiple/ 
unspecified 
infections 
 
Assessed risk of bias & rated 
overall strength of evidence for 
individual studies. 
9 intervention types with 55 
interventions  
 
Medium strength evidence: 
programs with communication 
skills & lab testing decrease 
ABX prescribing; low strength 
evidence (40 of the 55 
interventions): other 
interventions decrease ABX 
prescribing. 
Strengths: All studies 
outpatient & majority 
involved ARIs, good 
number studies.  
Limitations: 
Differences of 
interventions: difficult 
to pool results. 
Usefulness: Outpatient 
ABX stewardship 
interventions of all 
types decrease ABX 
prescribing. Many 
interventions 
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USA, Canada, 
Europe, UK, 
Middle East, 
Asia/Pacific 
region 
 multifaceted. Lab 
testing to help ABX 
stewardship is a 
favorable tool & 
communication 
showed promising 
results.  
Drekonja (2015) Detailed results 
Provider &/or patient education intervention (16 studies): most interventions were multifaceted, 6 studies found decreased ABX prescribing & 6 found no difference. 
Provider feedback intervention (5 studies): 3 associated with significant decreases in ABX prescribing.  
Guidelines intervention (6 studies): 3 found significant ABX decreases post-intervention. 
Delayed prescribing intervention (4 studies): 2 found reduction in ABX use in which 1 study provided education component. 
Communication skills training (6 studies): all involved multifaceted interventions, 5 reported significantly reduced ABX prescribing. 
Restriction policies intervention (2 studies): 1 showed decreasing trend in ABX prescriptions. 
Computerized clinical decision support (6 studies):  4 associated with decreased ABX prescribing.  
Financial incentives intervention (1 study): improved volume of prescribing & adherence to guidelines for only 2 of the 7 ABX studied. 
Laboratory testing interventions (9 studies): rapid antigen & C-reactive protein testing were associated with decreased ABX prescribing. 
First Author, 
(Year), Title, 
Journal 
Purpose & 
Study 
Timeframe 
Research 
Design1, 
Evidence Level 
(1-7)2, 
Variables3 
Setting, 
Sample4b (size), 
Sample Type, 
& Place 
Clinical 
Condition5, 
Provider6  
(size) & 
Patient Age7 
Measures, Reliability (if 
reported), Analysis Used, & 
Results 
Strengths, 
Limitations & 
Usefulness 
Computer Decision Support System Intervention (CDSS) 
Litvin (2012). 
Use of an 
electronic health 
record clinical 
decision support 
tool to improve 
antibiotic 
prescribing for 
acute respiratory 
Analyze the 
effect of CDSS 
on ABX 
prescribing for 
ARI in primary 
care. 
 
Jan. 2010 to 
March 2012 
Quantitative, 
quasi-
experimental 
Level 3 
 
IV: intervention 
consisting of 
CDSS as 
template with 
9 primary care 
practices in a 
practice-based 
research 
network  
 
Patients (38,592 
for total study 
time)  
Allergic 
rhinitis, 
asthma, 
bronchitis or 
bronchiolitis, 
COPD 
exacerbation, 
laryngitis or 
tracheitis, non-
Entire 27-month study course 
 
Weighted means and 95% CI 
determined for outcome 
measures during 1st quarter of 
interventions. General linear 
mixed models for longitudinal 
analyses to compare changes 
Strengths: Study done 
over 9 states, 
sustainable over 27 
months, multiple 
factors affect 
prescribing of ABX 
for ARI, positive 
impact of CDSS to use 
narrow-spectrum ABX 
ROAR INTERVENTION 58 
infections: the 
ABX-TRIP 
study. Journal of 
General Internal 
Medicine 
diagnostic 
pathways, 
guidelines for 
ABX 
prescribing, 
academic 
detailing and 
training, audit 
& feedback 
(ABX-TRIP 
CDDS) 
 
DV: % 
prescribed ABX 
 
Practices 
volunteered to 
participate in 
study   
 
9 states (NC, 
KY, WA, AK, 
AZ, MS, UT, 
GA, IL), USA 
 
 
suppurative 
otitis media, 
pharyngitis or 
tonsillitis, 
pneumonia, 
sinusitis, 
streptococcal 
pharyngitis, 
suppurative 
otitis media, 
URI 
 
MD (27), NP 
(6), PA (6) 
 
C, A 
over time. p<0.05 statistically 
significant 
 
ABX use for when ABX are 
rarely appropriate did not 
significantly change: estimated 
1.57% in adults [95% CI -5.35 
to 8.49%] and -1.89% in 
children [95% CI -9.03 to 
5.26%]). Broad-spectrum ABX 
decreased significantly 
(16.30% in adults (p<0.05) & 
16.30% in children).  
Broad-spectrum ABX 
decreased for sinusitis (19.74% 
p<0.05) & bronchitis 
(11.71%). 
Limitations: No 
control group & no 
way to affirm changes 
not due to secular 
trends, small group of 
volunteer practices, 
multifaceted 
intervention not able 
to tell which 
intervention more 
effective 
Usefulness: 
multifaceted 
intervention, 
sustainable with 
decreasing broad-
spectrum ABX use for 
ARI, primary care 
       
Mainous (2013). 
Impact of a 
clinical decision 
support system 
on antibiotic 
prescribing for 
acute respiratory 
infections in 
primary care: 
quasi-
experimental 
trial. Journal of 
the American 
Medical 
Assess effect 
of CDSS 
integrated into 
EHR on ABX 
prescribing for 
ARIs. 
 
Oct. 2009 to 
March 2011 
Quantitative, 
quasi-
experimental 
Level 3 
 
IV: intervention 
consisting of 
CDSS as a 
template with 
diagnostic 
criteria to assist 
diagnosis, 
antibiotic 
guidelines, 
70 primary care 
practices 
 
9 control 
practices 
volunteered.  61 
control 
practices were 
chosen due to 
specific site 
requirements. 
 
9 states, USA 
Non-specific 
URI, otitis 
media with 
effusion, 
bronchitis, 
pharyngitis, 
COPD 
exacerbation, 
otitis media, 
strep 
pharyngitis, 
PNA, sinusitis 
 
Pre- & post-intervention data 
Compared baseline between 
groups with independent-
sample t tests. Compare 
changes among groups over 
time with linear mixed models. 
 
In adults, inappropriate ABX 
prescribing for ARIs decreased 
0.6% (p=0.03) in intervention 
group but increased 4.2% in 
control group. In peds this was 
increased in intervention group 
1.4% (p=0.34) & control group 
Strengths: Study 
adjusted potential 
confounding variables 
to increase validity of 
research design.  
Limitations: Requires 
computerized EHR. 
Providers can change 
diagnosis to justify 
ABX use.  
Confounder: study 
overlapped with 2009 
H1N1 flu pandemic. 
Individual prescribing 
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Informatics 
Association 
(JAMIA) 
audit & 
feedback 
 
DV: % 
prescribed ABX 
MD (27), NP 
(6), PA (6) 
 
All ages 
4.2%.  Broad-spectrum ABX 
use declined in intervention 
group with adults (16.6%) & 
ped (19.7%) (each p<0.0001) 
compared to increase in 
control group (1.2% adult, 
0.9% ped). Patients with ARI 
less likely to receive broad-
spectrum ABX if template 
used (adult: 45.9% vs. 56.8% 
p<0.004, ped: 24.6% vs. 35% 
p<0.0001). little evidence of 
diagnostic shift. 
data not available. 
Difficult to determine 
if CDSS alone would 
be effective strategy. 
Usefulness:  Modest 
effect in decreasing 
inappropriate ABX 
prescribing in adults, 
substantial impact on 
decreasing use of 
broad-spectrum ABX 
in all ages. 
       
Rattinger (2012). 
A sustainable 
strategy to 
prevent misuse of 
antibiotics for 
acute respiratory 
infections. Public 
Library of 
Science (PLOS) 
ONE 
Determine if 
CDSS 
embedded in 
EHR at time of 
order entry for 
selected ABX 
would adjust 
ABX 
utilization 
toward 
treatment 
guidelines for 
ARIs. 
Quantitative, 
quasi-
experimental 
Level 3 
 
IV: intervention 
consisting of 
CDSS tool 
targeting 
gatifloxacin and 
azithromycin 
 
DV: % 
prescribed ABX 
2 outpatient 
clinics  
Patients (pre 
717 / post 
3,114) 
 
Convenience 
sample of 
patients 
 
Maryland, USA 
(intervention 
site) 
 
Salt Lake City, 
USA (control 
site) 
PNA, 
bronchitis, 
sinusitis, 
nonspecific 
acute 
respiratory 
infection 
 
Attending 
physicians & 
medical 
students 
 
A, EP 
(16-97 years) 
without COPD 
Pre- & post- intervention data. 
Multivariable logistic 
regression & difference-in-
difference regression analyses 
to estimate effect of CDSS 
intervention on overall ABX 
prescribing accordance. 
 
The targeted ABX remained 
most prescribed of the 
warranted (justified) ABX.  
Utilizing the CDDS, the 
proportion of unwarranted use 
of gatifloxacin & azithromycin 
decreased from 22% to 3.3% 
(p <0.0001).  Proportion of 
total ARI where ABX use was 
in accord with guidelines 
increased in intervention site 
Strengths: Long 
duration, large sample 
size, sustainable after 
4 yrs.  
Limitations: Need 
computer charting, 
study not randomized, 
implemented at only 
one site, may not be 
generalizable, 
population mostly 
male adults, dealt with 
attempt to reduce 
prescribing of only 2 
ABX 
Usefulness: 
embedding CDSS into 
program can help deter 
prescribing ABX for 
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(p=0.0001) but unchanged at 
control site (p=0.10). 
unwarranted 
conditions, but need 
limitations on more 
broad-spectrum ABX.  
       
Gonzales (2013). 
A cluster-
randomized trial 
of decision 
support strategies 
for reducing 
antibiotic use for 
acute bronchitis. 
JAMA Internal 
Medicine 
Compare the 
effect of 2 
decision 
support 
strategies on 
ABX treatment 
of 
uncomplicated 
acute 
bronchitis. 
Quantitative, 
RCT 
Level 2 
 
IV: intervention 
consisting of 
printed decision 
support (PDS) 
or computerized 
decision 
support (CDS), 
provider 
education and 
feedback & 
patient 
education 
 
DV: % 
prescribed ABX 
33 primary care 
practices  
Patients (9,808 / 
6,242)  
 
3-arm cluster 
randomization 
of 
implementation 
strategies to 
determine study 
(11 printed or 
11 
computerized 
intervention) & 
11 control 
groups (no 
intervention) 
 
Pennsylvania, 
USA 
Acute 
bronchitis & 
bronchitis, not 
otherwise 
specified 
 
MD, NP, PA 
 
Ad, A 
(> 13 & < 64) 
without 
comorbidities 
& ABX 
responsive 
secondary 
diagnoses 
Pre- & post-intervention data 
Used generalized estimating 
equations & alternating logistic 
regression. p<0.05 statistical 
significant 
 
% of ABX prescribed during 
intervention period decreased 
at PDS sites (80% to 68.3%, 
p=0.003) & CDS sites (74% to 
60.7%, p=0.014), but increased 
at control sites (72.5% to 
74.3%).  About 1/3 providers 
decreased ABX prescription 
rates by over 20% at PDS & 
CDS sites. No significant 
difference in return visits 
between baseline & 
intervention periods. 
Strengths: Large 
sample, multiple 
settings, multifaceted 
intervention, time 
frame during winter 
periods (Oct to March) 
captured increased 
occurrences of 
diagnoses. 
Limitations: Sites rural 
/semi-rural practices, 
short duration of time 
frame studied, subject 
to Hawthorne effect, 
not able to determine 
which intervention 
was more effective. 
Usefulness: Paper & 
computer evidence-
based can reduce ABX 
prescribing.   
       
Jenkins (2013). 
Effects of clinical 
pathways for 
common 
outpatient 
infections on 
Determine 
effects of 
decision 
support clinical 
pathways on 
Quantitative, 
quasi-
experimental 
Level 3 
 
8 outpatient 
clinics  
Patients (31,368 
/ 17,022) 
 
Nonspecific 
URI, acute 
bronchitis, 
acute 
rhinosinusitis, 
acute 
Pre- & post-intervention data  
Generalized linear mixed 
effects model to analyze trends 
in ABX prescriptions for non-
PNA URI & broad-spectrum 
ABX use. Pearson X2 test: 
Strengths: Large 
sample, multiple 
settings, multifaceted 
intervention, obtained 
1-yr post intervention 
data. 
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antibiotic 
prescribing. The 
American 
Journal of 
Medicine 
ABX 
prescribing. 
IV: intervention 
consisting of 
clinical 
pathways, 
patient 
education, & 
peer advocate 
 
DV: % 
prescribed ABX 
Convenience 
sample of 
providers with 
stratified 
randomization 
of clinics to 
determine 4 
study 
(intervention) & 
4 control group 
(no 
intervention) 
 
Denver, USA 
 
pharyngitis, 
acute otitis 
media, UTI, 
STI, PNA 
 
MD (80) 
 
C, Ad, A 
proportion of ABX 
prescription. Piecewise 
logistics regression model 
assessed pre-post. 
 
Study group showed 11% 
relative reduction (42.7% to 
37.9%, p<0.0001) ABX use for 
non-PNA URI & 14% relative 
reduction (26.4% to 22.6%, 
p<0.001) in use of broad-
spectrum ABX. Control group 
overall change in ABX 
prescribing not statistically 
significant, provided ABX 
2.8% less frequently (from 
39.8% to 38.7%, p=0.25) & 
used broad-spectrum ABX 3% 
less frequently (from 20.0% to 
19.4%, p=0.35).  
Limitations: 
Prescribing rates 
underestimated due to 
networks used, 
misclassification 
electronic data, study 
subject to Hawthorne 
effect, adverse event 
data not available for 4 
clinics, unable 
determine which 
intervention more 
effective, unknown 
sustainability. 
Usefulness: 
Generalizable 
multifaceted 
intervention can be 
utilized to decreased 
ABX prescribing for 
URIs & use of broad-
spectrum ABX at other 
facilities. 
Academic Detailing Intervention 
Regev-Yochay 
(2011). 
Reduction in 
antibiotic use 
following a 
cluster 
randomized 
controlled 
multifaceted 
Assess whether 
intervention 
among 
physicians and 
patients attain 
a continued 
decrease in 
antibiotic use. 
Quantitative, 
cluster RCT 
Level 2 
 
IV: intervention 
consisting of 
focus group 
meetings, 
workshops, 
Primary care 
pediatric solo 
practices 
 
MDs placed in 
control or 
intervention 
group by 
URI, fever, 
otitis media, 
pharyngitis, 
common cold, 
PNA 
 
MD 
(pediatricians) 
Pre- &post- intervention data 
Mixed-effect models used to 
assess change in ABX 
prescribing rate.  Multilevel 
Poisson regression analysis. 
 
Parents’ wish for ABX 
decreased 47%.  At participant 
level, reduced prescription rate 
Strengths: Large 
pediatric population, 
long-standing 
multifaceted 
intervention to observe 
sustained effect.                                                                                                                                                                                                                                                                                                                                                                      
Limitations: 
Nationwide campaign 
occurred during 2nd & 
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intervention: The 
Israeli judicious 
antibiotic 
prescription 
study. Clinical 
Infectious 
Diseases 
seminars, 
practice 
campaigns, 
education, 
parent-
physician 
communication, 
ABX 
prescription rate 
feedback 
 
DV: % 
prescribed ABX 
stratified 
randomization 
 
Israel 
24 in control 
group, 26 in 
intervention 
group 
 
C, Ad 
(<18 years) 
 
included all ABX classes but 
most prominent for 
macrolides: intervention (58%) 
control (27%), relative risk 
0.58, 95% CI 0.55-0.62).  
During 2nd & 3rd year of study 
ABX rates decreased by 22% 
(control group) & 40% 
(intervention group) (RR 0.76, 
95% CI 0.75-0.78) – sustained 
after 4 yrs. At physician level, 
reduced overall prescription 
rate significantly greater in 
intervention than control (RR 
0.89, 95% CI 0.81-0.98). 
3rd year of study 
causing a significant 
reduction in each 
group ABX rates 
(confounder), unable 
to determine effect of 
each component in 
multifaceted 
intervention. 
Usefulness: Long 
standing multifaceted 
intervention which 
providers have active 
roles in focus groups 
to develop guidelines 
& promote awareness 
can decrease ABX 
prescribing.  
       
Butler (2012). 
Effectiveness of 
multifaceted 
educational 
programme to 
reduce antibiotic 
dispensing in 
primary care: 
practice based 
randomized 
controlled trial. 
British Medical 
Journal (BMJ) 
Evaluate 
effectiveness 
& costs of 
multifaceted 
educational 
program aimed 
at reducing 
ABX 
dispensing. 
Quantitative, 
RCT 
 
Level 2 
 
IV: intervention 
consisting of 
audit & 
feedback, 
online 
education, 
guidelines, 
communication 
68 primary care 
practices  
Patients served 
(480,000) 
 
Randomization 
of all practices 
then utilized 
dynamic block 
allocation to 
assign clinicians 
to intervention 
& control 
groups (34 
All conditions 
 
244 clinicians 
(117 in control 
group, 127 in 
intervention 
group) 
 
All ages 
Pre- & post- intervention data 
Main analysis: intention to treat 
& compared groups’ annual 
rates of total ABX dispensing by 
ANCOVA.  Other outcomes: 
average hospital admission rates 
for complications between two 
groups. Re-consultation rates 
compared with Mann-Whitney 
U tests. 
 
Rate of ABX dispensing (items 
per 1000 patients) intervention 
group with 4.2% decreased 
(p=0.02) in total ABX 
Strengths: Intervention 
discussed practice 
specific ABX 
dispensing & 
resistance rates, 
reported association 
between reduction in 
dispensing & local 
resistance levels. 
Limitations: Lack of 
diagnosis led to not 
knowing which 
condition decrease in 
ABX associated with.  
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skills (STAR 
program) 
 
DV: total 
number of ABX 
dispensed per 
1000 practice 
patients 
practices in 
each) 
 
Wales, United 
Kingdom 
dispensing. Reductions found 
for all classes of ABX other 
than penicillinase-resistant 
penicillins (p=0.43).  No 
significant difference between 
groups with hospital admission 
or re-consultations.  Mean 
annual cost of ABX dispensing 
fell in both groups, greater in 
intervention group (5.5% 
decrease, p=0.07). 
Unable to determine 
which clinician 
responded most to 
intervention.  
Usefulness: It is 
possible to reduce 
ABX prescribing for 
all causes utilizing a 
multifaceted program. 
       
Gerber (2013). 
Effect of an 
outpatient 
antimicrobial 
stewardship 
intervention on 
broad-spectrum 
antibiotic 
prescribing by 
primary care 
pediatricians. 
Journal of the 
American 
Medical 
Association 
(JAMA) 
Evaluate the 
impact of an 
antimicrobial 
stewardship 
intervention on 
ABX 
prescribing for 
pediatric 
outpatients. 
Quantitative, 
cluster RCT 
Level 2 
 
IV: intervention 
consisting of 
clinician 
education with 
audit and 
feedback of 
ABX 
prescribing 
 
DV: % 
prescribed ABX 
18 pediatric 
primary care 
practices  
Patients 
(478,012 / 
293,320) 
 
Block-
randomized 
practices 
(cluster) by 
location & 
volume 
 
Pennsylvania & 
New Jersey, 
USA 
Sinusitis, 
streptococcal 
pharyngitis, 
PNA 
 
MD, NP, 
trainees (81 
clinicians each 
control & 
intervention 
groups) 
 
C, Ad 
without 
complex 
chronic 
conditions, 
allergy to ABX 
or received 
ABX within 
prior 3 months 
Pre- & post- intervention data 
Piecewise generalized linear 
model: prescribing pre- post-
intervention between groups. 
 
Broad-spectrum ABX 
prescriptions decreased from 
26.8% to 14.3% (absolute 
difference 12.5%) among 
intervention & from 28.4% to 
22.6% (absolute difference 
5.8%) in control.  Broad-
spectrum ABX prescribing had 
significant decrease for PNA 
(11.5%, p<0.001) & sinusitis 
(10%, p=0.12) with little 
change for strep pharyngitis 
(1%, p=0.82) & viral 
infections (0.2%, p=0.93) with 
intervention.   
Strengths: 
Personalized audit & 
feedback with peer 
benchmarking, large 
sample, multiple 
settings, & 
multifaceted 
intervention. 
Limitations: Not able 
to tell which element 
decreased prescribing, 
unknown 
sustainability past 12 
months, trend in 
control group possibly 
due to contamination 
across practice sites. 
Usefulness: study did 
show significant 
decrease of broad-
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Prescribing for viral infections 
was low at baseline & did not 
change. 
spectrum ABX 
prescriptions.  
       
Grover (2013). 
Addressing 
antibiotic use for 
acute respiratory 
tract infections in 
an academic 
family medicine 
practice. 
American 
Journal of 
Medical Quality 
Educate 
providers & 
patient to 
decrease 
overall ABX 
prescription 
rates for ARTIs 
 
Dec 2009 to 
Jan 2011 
Quantitative, 
quasi-
experimental 
Level 3 
 
IV: intervention 
of consisting 
academic 
detailing (ABX 
prescribing 
rates, 
guidelines, 
material for 
patients) 
 
DV: % 
prescribed ABX 
2 primary care 
sites 
 
Clinicians 
participated in 
prior study; 
final sample of 
241 patients 
 
Scottsdale AZ, 
USA 
ARTIs 
 
17 providers: 
MD (15), NP 
(2) 
 
C, Ad, A 
(≥ 5 years) 
Pre- & post-intervention data 
Baseline ABX rates calculated; 
compared data from baseline 
to present data to determine 
difference in ABX prescribing 
rate, p <0.05 statistically 
significant. 
 
Adult overall ABX prescribing 
rate decreased 13% (p<0.001). 
Use of broad-spectrum ABX in 
adults decreased 9% (p=0.04) 
Patients with risk factors for 
complications of ARI 6x more 
likely to receive ABX 
(p<0.001) than those with no 
risk (46%). Diagnosis of 
sinusitis 8x (p<0.001) or 
bronchitis 20x (p<0.001) more 
likely to get ABX.  
Strengths: ABX use 
decreased substantially 
with diagnosis of URI. 
Limitations: Small 
patient sample, 
Hawthorne effect, 
short time frame of 
data collection (Dec to 
March), unknown if 
improved behaviors 
are sustainable.  
Usefulness: 
Multifaceted 
intervention involving 
clinician & patients, 
reducing use of ABX 
for ARIs & broad-
spectrum ABX use.  
       
Vinnard (2013). 
Effectiveness of 
interventions in 
reducing 
antibiotic use for 
upper respiratory 
infections in 
ambulatory care 
Evaluate the 
impact of 
separate 
interventions 
on ABX 
prescribing for 
uncomplicated 
URIs 
Quantitative, 
quasi- 
experimental 
Level 3 
 
Outpatient 
clinical settings 
 
Purposive 
sampling of 
providers  
#1 based on 
providers with 
  Strengths: Multiple 
interventions. 
Limitations: 
Possibility of 
contamination 
between groups, 
selection bias, & if 
findings generalizable. 
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practices. 
Population 
Health 
Management 
1st & 2nd highest 
prevalence of 
ABX in 1998  
#2 based on 
highest number 
of patient visits 
for diagnoses 
evaluated 
 
Pennsylvania, 
USA 
Usefulness: Academic 
detailing can reduce 
unnecessary ABX 
prescribing. Patient 
educational materials 
more successful in 
decreasing expectation 
of ABX if provided at 
time of visit. 
#1 IV: 
intervention 
consisting of 
academic 
detailing 
 
#1 DV: % 
prescribed ABX 
 
Intensive 
intervention 
group (7 
providers) – 
opinion leader, 
published 
literature & 
patient educ. 
material 
 
Mild 
intervention 
group (7 
provider) – 
patient educ. 
material only 
 
Control group 
(14 providers) – 
nothing 
provided 
Acute 
bronchitis, 
bronchitis not 
otherwise 
specified, 
cough, acute 
pharyngitis, 
acute URI 
 
All ages 
Pre- & post-intervention data 
Generalized linear regression 
model with time & 
intervention groups as main 
effects & time-by-intervention 
interaction term. 
 
10% reduction in ABX 
prescribing for intensive 
intervention group (compared 
to no intervention ratio of odds 
ratio 2.60, [1.23-5.48]). No 
significant change in control or 
mild intervention group. 
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#2 IV: 
intervention 
consisting of 
patient mailing 
 
#2 DV: % 
prescribed ABX 
Intervention 
group (48 
providers) – 
patient oriented 
educ. material, 
patients mailed 
educ. brochure 
& letter signed 
by provider 
 
Control group 
(22 providers) – 
nothing 
provided 
Acute 
bronchitis, 
bronchitis not 
otherwise 
specified, 
cough, acute 
pharyngitis, 
acute URI 
 
All ages 
Pre- & post-intervention data 
Broad-spectrum ABX 
prescribing. 
Determined prevalence of 
ABX prescribing then 
piecewise generalized linear 
regression model to account 
for correlation within 
providers. 
Prescribing rate pre-post: 
intervention group decreased 
4.7%, control group increased 
1.2%. Not statistically 
significant (p=0.133). No 
change in broad/narrow 
spectrum ABX use. 
Guideline Intervention 
Weiss (2011). 
Impact of a 
multipronged 
education 
strategy on 
antibiotic 
prescribing in 
Quebec, Canada. 
Clinical 
Infectious 
Diseases 
Assess effect 
of 
multipronged 
education plan 
on number and 
cost of ABX 
prescriptions.  
Quantitative, 
quasi-
experimental 
Level 3 
 
IV: intervention 
consisting of 
guidelines 
providing 
clinical 
information & 
ABX 
recommendatio
ns 
DV: % 
prescribed ABX 
All outpatient 
practices 
 
Bundle 
approach 
 
Quebec, Canada 
Upper 
respiratory 
(pharyngitis, 
otitis media, 
sinusitis), 
lower 
respiratory 
(bronchitis, 
PNA), UTI, C. 
difficile 
infections 
 
MD & 
pharmacists 
 
All ages 
Pre- and post-intervention data 
Segmented regression analysis 
of interrupted time series to 
evaluate effect of guidelines 
distribution on ABX 
prescription & costs. 
Calculated difference in rates 
of ABX prescriptions & costs 
per 1000 inhabitants by 
subtracting the rate for the 
province of Quebec from the 
rates in other Canadian 
provinces. 
 
In Quebec, number of ABX 
decreased by 4.2% (p=0.002) 
Strengths: large 
population, sustained 
effect on ABX 
prescription 36 months 
later. 
Limitations: ABX 
guidelines produced in 
time where population 
aware of risks 
associated with ABX 
overuse (confounder) 
Usefulness: Guidelines 
endorsed by 
professionals, actively 
endorsed & dispersed 
can have sustained 
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in year after intervention & 
persisted 36 months compared 
to increase by 6.5% in other 
provinces. ABX cost decreased 
by 13% in Quebec during 
study period and barely 
decreased in other provinces. 
impact on ABX 
prescribing practices. 
       
Venekamp 
(2012). 
Treatment of 
acute 
rhinosinusitis: 
discrepancy 
between 
guideline 
recommendations 
and clinical 
practice. Family 
Practice 
Investigate 
whether 
consultation 
and 
prescription 
rates for acute 
rhinosinusitis 
changed after 
introduction of 
revised 
guidelines. 
 
2000-2009 
revised 
guideline 
introduced 
2005 
Quantitative, 
cohort study 
Level 4 
 
IV: revised 
guideline 
 
DV: % 
prescribed ABX 
Outpatient 
family practices 
 
Netherlands 
 
Total size of 
cohort was 
31,938 patients 
in 2000 and 
35,803 patients 
in 2009.  9631 
patients 
diagnosed with 
acute 
rhinosinusitis 
between 2000 
& 2009.  
 
Acute 
rhinosinusitis 
 
MD 
 
A 
(18 years) 
Pre- & post-intervention data  
ABX & intranasal steroid 
prescription rates calculated as 
number of prescriptions per 
100 acute rhinosinusitis 
episodes. Trend analysis over 
years 2005-09: calculated rate 
differences. 
 
2000 to 2005 (before revised 
guidelines) ABX prescription 
rate increased 6 prescriptions 
per 100 episodes (p=<0.05).  
From 2005 onwards (after new 
guidelines), ABX prescription 
rate decreased 6 per 100 
episodes in 2009; rate 
difference -6 (p<0.05). 2000 to 
2009 intranasal steroid 
prescription rate increased 11 
prescriptions per 100 (p<0.01). 
Strengths: Size of 
cohort & quality of 
data. 
Limitations: Other 
determinants could 
have decreased ABX 
prescription rate over 
time, only looked at 
one condition. 
Usefulness: Guidelines 
can be used with other 
interventions to help 
decrease ABX 
prescribing.  
       
Meeker (2014). 
Nudging 
guideline-
Investigate use 
of posted 
commitment 
Quantitative, 
randomized 
clinical trial 
5 outpatient 
primary care 
clinics 
Nasopharyngiti
s, laryngitis, 
bronchitis, 
Pre-& post-intervention data 
Logistic mixed effects model 
Strengths: Low-cost. 
Promotes shared 
decision making 
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concordant 
antibiotic 
prescribing: a 
randomized 
clinical trial. 
JAMA Internal 
Medicine 
letter 
(behavioral 
nudge) in 
encouraging 
judicious use 
of ABX for 
ARIs. 
Level 2 
 
IV: intervention 
consisting of 
poster-sized 
commitment 
letters in exam 
rooms 
 
DV: % 
prescribed ABX 
Volunteer 
providers 
meeting criteria 
then 
randomized to 
control & 
intervention 
(7 providers 
each) 
 
Los Angeles 
CA, USA 
URI, 
bronchitis, 
pharyngitis, 
influenza 
 
MD (11), NP 
(3) 
 
A 
(18 years) 
predicted inappropriate ABX 
prescribing; 95% CI.   
 
Inappropriate ABX prescribing 
decreased (9.8%) intervention 
group (95% CI 0 to -19.3), 
increase (9.9%) control group. 
Relative to control, posted 
commitment letter resulted in 
19.7 absolute % reduction in 
inappropriate ABX prescribing 
(p=0.02).  
between provider & 
patient. 
Limitations: Limited 
number of clinics, 
small number of 
clinicians, & limited 
time of observation.  
Usefulness: Simple, 
low-cost intervention 
(using posters alone) is 
effective in decreasing 
ABX prescribing for 
ARIs.  
Feedback Intervention 
Naughton (2009). 
A RCT 
evaluating the 
effectiveness and 
cost-
effectiveness of 
academic 
detailing versus 
postal 
prescribing 
feedback in 
changing GP 
antibiotic 
prescribing. 
Journal of 
Evaluation in 
Clinical Practice 
Evaluate 
efficacy of 
academic 
detailing plus 
mailed 
prescribing 
feedback vs. 
only mailed 
prescribing 
feedback in 
decreasing 
overall rate of 
ABX 
 
March 2004 to 
March 2006 
Quantitative, 
RCT 
Level 2 
 
IV: intervention 
consisting of 
academic 
detailing & 
postal 
prescribing 
feedback (AD) 
vs. postal 
prescribing 
feedback alone 
(PB) 
 
DV: % 
prescribed ABX 
98 outpatient 
practices 
 
98 Volunteered 
practices were 
randomized to 
either 
intervention.  
 
AD: 48 
practices w/ 55 
GPs 
 
PB: 50 practices 
w/ 55 GPs 
 
Ireland 
Clinical 
condition not 
identified 
 
MD 
 
All ages 
Pre- & post-intervention data 
Interrupted times series 
segmented regression: examine 
within & between-group 
changes in prescribing in pre- 
& post-intervention. 
Regression coefficients 
indicating monthly % change 
in prescribing, 95% CI. 
 
Each intervention: 2% 
decrease in the rate of ABX 
prescribing (p=0.26). AD 
group significantly increased 
narrow-spectrum ABX 
prescribing by 5% & 2% in PB 
group (p=0.04). After 12 
months, each group returned to 
pre-intervention prescribing. 
Strengths: intervention 
able to alter pattern of 
ABX selection & 
decrease ABX use 
short term. 
Limitations: Lack of 
participation by all & 
lack of follow-up may 
have reduced 
effectiveness of 
interventions & long 
term sustainability not 
achieved.  
Usefulness: Academic 
detailing along with 
face-to-face provider 
feedback coupled with 
guidelines might have 
more of an impact. 
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Linder (2010). 
Electronic health 
record feedback 
to improve 
antibiotic 
prescribing for 
acute respiratory 
infections.  
American 
Journal of 
Managed Care 
Examine 
whether 
providing EHR 
feedback 
improves 
quality of care 
& reduces 
inappropriate 
ABX 
prescribing for 
ARIs. 
 
Nov 27, 2006 
to Aug 31, 
2007 
Quantitative, 
cluster RCT 
Level 2 
 
IV: intervention 
of EHR 
feedback with 
monthly 
reminders 
 
DV: % 
prescribed ABX 
27 primary care 
practices 
 
Practices cluster 
randomized to 
control or 
intervention 
 
Intervention 
group: 14 
practices w/ 258 
clinicians, 8406 
visits for ARI 
 
Control group: 
13 practices w/ 
315 clinicians, 
10,082 visits for 
ARI 
 
Massachusetts, 
USA 
ABX 
appropriate: 
PNA, strep 
pharyngitis, 
sinusitis, otitis 
media 
ABX 
inappropriate: 
pharyngitis, 
flu, acute 
bronchitis, 
nonspecific 
URI 
Intervention 
group: MD 
(154), Resident 
or Fellow 
(102), NP or 
PA (2) 
Control group: 
MD (188), 
Resident or 
Fellow (122), 
NP or PA (5) 
 
All ages 
Post-intervention data 
Standard descriptive statistics 
to compare clinicians & 
patients, Χ2 test for categorical 
variables & t test for 
continuous variables. p<0.05 
considered significant. 
 
No difference between 
intervention & control in ABX 
prescribing for ARI visits 
(p=0.87), ABX appropriate or 
non-appropriate ARI visits. 
Only 28% usage of EHR 
feedback, but those users had 
lower overall ARI ABX rate 
(42%, p=0.02) versus non-
users (50%) & non-ABX 
appropriate ARIs (32%, 
p=0.004) versus on-users 
(43%). 
Strengths: Adequate 
number of patients 
assessed 
Limitations: No pre-
intervention data of 
ABX use, decreased 
usage of EHR 
feedback tool, short 
duration of study. 
Usefulness: Feedback: 
useful info to increase 
awareness of ABX 
usage. Active 
dissemination better. 
Incorporating this with 
other interventions 
may be more effective 
in decreasing ABX 
prescribing.  
       
Gjelstad (2013). 
Improving 
antibiotic 
prescribing in 
acute respiratory 
Assess effects 
of multifaceted 
educational 
intervention to 
reduce ABX 
Quantitative, 
cluster RCT 
Level 2 
IV: intervention 
consists of 
79 general 
practice groups 
 
Randomization 
stratified by 5 
URI, tonsillitis, 
sinusitis, 
bronchitis, 
PNA, otitis 
media & other 
Pre- & post- intervention data 
Multilevel logistic regression 
models, compared post-
intervention data for 
intervention & control.   
Strengths: Large study 
including 10% of all 
general practitioners.  
Participants received 
CME credit.  
ROAR INTERVENTION 70 
tract infections: 
cluster 
randomized trial 
from Norwegian 
general practice 
(prescription peer 
academic 
detailing (Rx-
PAD) study). 
British Medical 
Journal (BMJ) 
prescribing 
rates for ARTIs 
& reduce use 
of broad-
spectrum 
ABX. 
academic 
detailing – 
guidelines, 
audit & 
feedback, 
teaching 
seminar 
(intervention 
group) & 
intervention 
consisting 
academic 
detailing of 
appropriate 
drug treatment 
in patients >70 
years – 
excluding ABX, 
audit & 
feedback, 
teaching 
seminar 
(control group) 
 
DV: % 
prescribed ABX 
 
geographical 
regions, then 
within each 
stratum further 
randomized  
(39 practices in 
intervention & 
40 practices in 
control group) 
 
Norway 
(southern 
counties) 
respiratory 
tract infections 
 
382 clinicians 
(199 in control 
group & 183 in 
intervention 
group) 
 
All ages 
 
1.4% reduction of ABX 
prescribing rates in the 
intervention group (33.2% to 
31.8%) but a 1.6% increase in 
control group (33.4% to 
35.0%).  Prescribing of non-
penicillin V ABX per 1000 
patients decreased from 6.1 in 
intervention & increased from 
6.8 in control. Less use of non-
penicillin V ABX in bronchitis, 
sinusitis & PNA along with 
reduced ABX prescription rate 
for bronchitis. 
Limitations: Data did 
not allow separation of 
initial from follow-up 
encounters possibly 
underestimating ABX 
rates in patients with 
PNA.  Used 13 
different academic 
detailers could have 
influenced effect of 
intervention. 
Usefulness:  Possible 
to reduce ABX 
prescribing for ATRIs 
& decrease broad-
spectrum ABX use 
utilizing academic 
detailing intervention. 
Communication Skills Intervention 
Altiner (2007). 
Reducing 
antibiotic 
prescriptions for 
acute cough by 
Assess efficacy 
of 
communication 
strategy 
intervention to 
Quantitative, 
RCT 
Level 2 
 
Outpatient 
practices 
 
Volunteered GP 
cluster 
Acute cough 
 
MD 
 
Ad, A 
Pre- & post-intervention data 
Baseline characteristics 
compared between groups, to 
exclude confounding effects 
performed two parallel 
Strengths: Multiple 
regions with adequate 
number of patients in 
study. 
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motivating GPs 
to change their 
attitudes to 
communication 
and empowering 
patients: A 
cluster-
randomized 
intervention 
study. Journal of 
Antimicrobial 
Chemotherapy 
reduce 
unnecessary 
ABX 
prescriptions 
for acute 
cough. 
 
Nov 2003 to 
March 2005 
IV: intervention 
consisting of 
peer visits to 
focus on 
communication 
with patients 
exploring their 
expectations & 
demands. 
Patients 
received 
evidence-based 
information 
about illness & 
ABX 
 
DV: % 
prescribed ABX 
randomization 
of practice to 
intervention or 
control group 
 
Intervention 
group: baseline 
52 GPs w/ 1389 
pts, 6 wks. after 
intervention 42 
GPs w/ 1021 
pts, 12 mo. after 
intervention 28 
GPs w/ 787 pts. 
Control group: 
baseline 52 GPs 
w/ 1398 pts, 6 
wks. after 
intervention 44 
GPs w/ 1143 
pts, 12 mo. after 
intervention 33 
GPs w/ 920 pts. 
Germany (9 
regions) 
(16 years)  analyses of data. Relative 
changes from baseline reported 
as odds ratios. 
 
Intervention group ABX rate 
decreased 7% (p<0.001) @ 6 
weeks after intervention and 
increased to baseline after the 
year (p=0.028). Control group 
ABX rate increased to 4.7% 
(p=0.001) @ 6 weeks after 
intervention & increased 
another 5.4% after the year 
(p=0.044).  
The odds ratio corresponds to a 
relative reduction in ABX 
prescription rates of ~60% at 6 
weeks & continual 40% at 12 
months. 
 
 
Limitations: % of GPs 
dropped out of study 
(was equal in both 
groups), Jan 2004 
OTC medicines 
excluded from 
reimbursement 
possibly increasing 
ABX use. 
Usefulness: 
Communication 
strategies involving 
shared decision 
making with patients 
& patient education 
resulted in immediate 
decrease of ABX 
prescribing and was 
sustained over year 
period without further 
interventions. 
       
Légaré (2012). 
Training family 
physicians in 
shared decision-
making to reduce 
to overuse of 
antibiotics in 
Evaluate effect 
of a shared 
decision-
making 
training 
program on 
percentage of 
Quantitative, 
cluster RCT 
Level 2 
IV: intervention 
consisting of 
online & 
interactive 
9 outpatient 
family practices 
Cluster 
randomization 
of practices to 
intervention or 
control group 
ARI 
 
Intervention 
group: MD & 
residents (77) 
 
Pre- & post-intervention data 
Generalized linear mixed 
model procedure to determine 
% of patients who decided to 
use ABX immediately after 
consultation.  
Strengths: Multiple 
regions viewed. 
Limitations: Did not 
control for other 
external variables, 
small sample size 
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acute respiratory 
infections: A 
cluster 
randomized trial. 
Canadian 
Medical 
Association 
Journal 
patient who 
decides to take 
ABX after 
consultation 
with clinician. 
 
July 2010 to 
April 2011 
seminars 
(shared decision 
making, 
education of 
signs and 
symptoms, 
communication 
strategies, & 
decision 
support tools) 
(DECISION+2) 
 
DV: % 
prescribed ABX 
then stratified 
according to 
location 
 
Intervention 
group: 5 
practices, 181 
pts 
Control group: 
4 practices, 178 
pts 
6 regions in 
Quebec 
Control group: 
MD & 
residents (72) 
 
All ages 
Cochran-Armitage trend test to 
assess perception that shared 
decision-making occurred & 
quality of decision made.  
 
% of patients who decided to 
use ABX after consultation 
increased 13% control group & 
decreased 14% intervention 
group, absolute difference of 
25%. DECISION+2 associated 
with patients’ active role in 
decision-making process 
(49%) vs. control group (67%), 
z=3.9, p<0.001. 
Usefulness: 
Multifaceted 
intervention involving 
communication 
strategies & shared 
decision making with 
patients is effective at 
decreasing ABX 
prescribing for ARIs.  
       
Little (2013). 
Effects of 
internet-based 
training on 
antibiotic 
prescribing rates 
for acute 
respiratory-tract 
infections: A 
multinational, 
cluster, 
randomised, 
factorial, 
controlled trial. 
Lancet 
Assess whether 
internet-based 
training 
methods could 
alter 
prescribing 
practices in 
multiple 
health-care 
systems. 
 
Oct - Dec 2010 
(baseline data) 
Feb - May 
2011(recruit 
patients) 
Quantitative, 
RCT 
Level 2 
 
IV: intervention 
of C-reactive 
protein (CRP) 
testing or 
communication 
training or both 
 
DV: % 
prescribed ABX 
246 outpatient 
practices 
Practices cluster 
randomized to 4 
groups 
 
Control: 53 
clinics w/ 870 
pts. 
CRP testing: 58 
clinics w/ 1062 
pts. 
Communication
: 55 clinics w/ 
1170 pts. 
CRP & 
communication 
Lower & 
Upper 
respiratory 
tract infections 
 
MD 
 
Ad, A 
(>18 years) 
Pre- & post-intervention data 
Analysis done by intention to 
treat & used multilevel logistic 
regression modeling to assess 
ABX use. Secondary analysis 
done for individual groups.  
 
Baseline ABX rate 55.3%.  
Post intervention: ABX rate 
increased 3.1% in control, 
decreased 15% CRP & 9% 
communication (each with 
p<0.0001).  
 
Individual group results: ABX 
rate increased 3.3% in control 
& decreased in CRP 20.3% 
Strengths: Large 
numbers patients & 
clinics, multiple 
countries, 
interventions 
transferable between 
settings.  
Limitations: 
Diagnostic value of 
CRP testing.  
Usefulness: 
Multifaceted 
communication 
intervention effective 
in decreasing ABX 
prescribing. CRP 
testing in patients 
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(both): 62 
clinics w/ 1162 
pts. 
 
6 European 
Countries 
(p<0.0001), communication 
14.3% (p=0.003), both 23.3% 
(p<0.0001).  
might not be feasible 
in all practices.!
 
 
 
ABX = antibiotic, RCT = randomized control trial, EHR = electronic health record 
1 Design: qualitative with specific design, quantitative with specific design, systematic review qualitative with meta-synthesis, systematic 
review quantitative, evidence based practice guideline (EBPG)  
2 Evidence Level: Hierarchy of evidence rated 1 to 7 per Melnyk & Fineout-Overholt (2015) 
3 Variables: independent (IV), dependent (DV) 
4a Sample = providers surveyed (#) 
4b Sample = patients served (# pre-intervention / # post-intervention) 
5 Clinical Condition: acute respiratory tract infection (ARTI or ARI), upper respiratory infection (URI), chronic obstructive pulmonary 
disorder (COPD), urinary tract infections (UTI), skin and soft tissue infections (STI), pneumonia (PNA) 
6 Provider: physicians (MD), nurse practitioners (NP), physician assistants (PA) 
7Patient Age: children (C), adolescent (Ad), adult (A) 
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Appendix B 
Application of Theory 
 
 
 
Figure B1.  DNP project conceptual framework.  Demonstrates affect antibiotic stewardship 
program has on changing healthcare providers antibiotic prescribing behavior for acute 
respiratory tract infections.  Numbers denote appropriate interventions as described in key.  
Adapted from Icek Ajzen’s theory of planned behavior. 
 
  
ROAR INTERVENTION 75 
 
Appendix C 
IRB Approval 
 
Figure C1. IRB authorization agreement. 
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Appendix C 
IRB Approval 
 
Figure C2. IRB Approval page 1 of 3. 
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Appendix C 
IRB Approval 
 
Figure C3. IRB Approval page 2 of 3. 
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Appendix C 
IRB Approval 
 
Figure C4. IRB Approval page 3 of 3. 
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Appendix D 
Site Approval Letter 
 
  
ROAR INTERVENTION 80 
 
Appendix E 
Cost for Reducing Outpatient Antibiotic Resistance Project 
Direct Costs Amount 
Printing AWARE brochures (color) 10.30 
Printing MARR clinical PEARLS (black and white) 2.10 
Printing course presentation and evaluations (black and white) 29.40 
Printing Snellman EBPG (black and white) 6.30 
Printing Snot Chart (color) 6.90 
Folders 4.00 
Printing consent forms 14.70 
Printing presentation flyers (black and white) 1.47 
Printing presentation flyers (color) 4.83 
Total Direct Costs 80.00 
Indirect Costs Amount 
Catered food for education sessions 120.00 
Gift cards for completion of survey @ $25/card for 8 cards 200.00 
Encrypted USB drive for data 50.00 
Dissemination of project @ APNO conference 678.00 
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Appendix F 
Study Recruitment Flyer 
!
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Appendix G 
Recruitment Script 
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Appendix H 
 
Presentation Evaluation 
 
 
 
Figure H1. Presentation evaluation page 1 of 2  
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Appendix H 
 
Presentation Evaluation 
!
 
Figure H2. Presentation evaluation page 2 of 2  
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Appendix I 
Informed Consent and Privacy Authorization 
 
Figure I1. Informed consent page 1 of 7  
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Appendix I 
Informed Consent and Privacy Authorization 
 
Figure I2. Informed consent page 2 of 7 
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Appendix I 
Informed Consent and Privacy Authorization 
 
Figure I3. Informed consent page 3 of 7  
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Appendix I 
Informed Consent and Privacy Authorization 
 
Figure I4. Informed consent page 4 of 7  
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Appendix I 
Informed Consent and Privacy Authorization 
 
Figure I5. Informed consent page 5 of 7  
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Appendix I 
Informed Consent and Privacy Authorization 
 
Figure I6. Informed consent page 6 of 7  
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Appendix I 
Informed Consent and Privacy Authorization 
 
Figure I7. Informed consent page 7 of 7  
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Appendix J 
Provider REDCap Questionnaire 
 
 
Figure J1. Email for provider questionnaire via REDCap  
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Appendix J 
Provider REDCap Questionnaire 
 
Figure J2. Provider questionnaire via REDCap page 1 of 4. 
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Appendix J 
Provider REDCap Questionnaire 
 
Figure J3. Provider questionnaire via REDCap page 2 of 4.  
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Appendix J 
Provider REDCap Questionnaire 
 
Figure J4. Provider questionnaire via REDCap page 3 of 4.  
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Appendix J 
Provider REDCap Questionnaire 
 
Figure J5. Provider questionnaire via REDCap page 4 of 4. 
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Appendix K 
1-Hour ROAR Presentation 
I.! Objectives 
1.! To promote antibiotic prescribing practice per guidelines to improve quality care. 
2.! To provide healthcare providers with literature and statistics related to antibiotic 
resistance and overuse. 
3.! To provide healthcare providers education regarding acute respiratory infections and 
treatment. 
4.! To provide healthcare providers with feedback regarding current antibiotic 
prescribing rates and beliefs and knowledge regarding antibiotic resistance and use. 
 
II.! Goals 
1.! To decrease healthcare provider antibiotic prescribing for acute respiratory infections. 
2.! To increase healthcare provider awareness of antibiotic resistance and stewardship. 
3.! To increase healthcare provider patient communication and education. 
 
III.! Problem and Significance 
1.! Antibiotic resistance 
a)! What is it? 
•! Antibiotic resistance is a phenomenon that happens when an antibiotic loses 
the ability to successfully eradicate bacterial growth (Institute of Medicine 
[IOM], 2010). 
b)! When was it first detected? 
•! Identified as early as 1940 with penicillin-R Staphylococcus prior to the 
widespread use of penicillin in 1943 (Centers for Disease Control and 
Prevention [CDC], 2013). 
c)! How is it caused? 
•! The emergence of drug-resistant bacteria can be attributed to the evolution of 
microbes but also by inappropriate use of antibiotics to treat non-bacterial 
infections (Agency for Healthcare Research and Quality [AHRQ], 2014; 
CDC, 2013). 
d)! Antibiotic resistance is a global healthcare crisis 
•! According to the literature, most US healthcare providers are aware of 
antibiotic resistance (Abbo et al., 2011; Abbo, Smith, Pereyra, 
Wyckoff, & Hooton, 2012; McCullough, Rathbone, Parekh, 
Hoffmann, & Mar, 2015; Rezal et al., 2015) in which 98% deem it to 
be serious (McCullough et al., 2015). Studies show 92% to 94% of US 
healthcare providers believe antibiotic resistance is a national problem 
(Abbo et al., 2011, 2012; McCullough et al., 2015) yet only 89% 
believe it is a global problem (McCullough et al., 2015). 
 
ROAR INTERVENTION 98 
 
 
Source: World Health Organization (2014) 
•! This map depicts resistance on 9 selected bacteria-antibacterial drug-
resistance combinations with the darkest green showing >5.  As you can see, 
the US along with Canada, eastern portion of Brazil, Europe, Russia, China, 
Australia and scattered portions of Africa all have >5 bacteria reported.  Data 
was not available for the portions on the map that are either white or have a 
diamond pattern. 
 
   
 
Source: Center for Disease Dynamics, Economics & Policy (2016) 
•! These maps show resistance of specific organisms to a specific antimicrobial 
agent in 2012.  The darker the blue, the higher the resistance. The left shows 
E. coli resistance to fluroquinolones, the top right showing staph aureus 
resistance to oxacillin and the bottom right showing staph aureus resistance to 
fluroquinolones. 
•! These organisms were chosen because these are common organisms 
that the urgent care centers come across. MO is in the West North 
Central Region. The left shows E. coli resistance to fluroquinolones 
with the West North Central at 18% resistant, the top right showing 
staph aureus resistance to oxacillin with West North Central at 43% 
resistant and the bottom right showing staph aureus resistance to 
fluroquinolones with West North Central at 43% resistant. 
 
2.! Overuse of antibiotics 
Approximately 50% of antibiotics prescribed are not necessary (AHRQ, 2014; CDC, 
2013), nevertheless antibiotics are one of the most often prescribed outpatient 
medications in the United States (Gerber et al., 2013; Lee et al., 2014). 
 
a)! Increased healthcare costs. 
In the United States, yearly antibiotic resistant infections lead to more than 8 
million additional hospital days and cost the healthcare system an excess of $20 
billion a year and $35 billion a year in lost wages (CDC, 2011). 
•! Between 2000 and 2010, utilization of antibiotic drugs increased by 36% in 
which the United States was the third largest consumer with an estimated 
9.2% of global consumption (Van Boeckel et al., 2014). 
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•! Lee et al. (2014) revealed from 2000 to 2010 there was an estimated 1.4 
billion outpatient antibiotics prescribed in the United States. 
•! In 2011, there was an estimated 8 million outpatient and emergency 
department (ED) visits for acute respiratory infections (ARIs) with the number 
of antibiotic prescriptions totaling almost 9.3 million (CDC, 2014a, b, c, d). 
 
b)! Increased adverse patient events. 
In the United States, there are over 2 million illnesses and at least 23,000 deaths 
yearly as a direct result of antibiotic-resistant infections (CDC, 2013).  
(http://www.cdc.gov/getsmart/community/images/materials/ar-deaths.jpg) 
 
(graphic CDC, 2016) 
 
•! According to the CDC (2012), adverse drug events cause 700,000 emergency 
department visits and 120,000 hospitalizations yearly resulting in an extra 
$3.5 billion in extra costs. 
•! Adverse drug events related to antibiotic use include: interactions with other 
drugs; side effects that commonly cause rash, nausea, vomiting, abdominal 
pain, headaches, etc.; allergic or hypersensitivity reactions e.g., Stevens 
Johnson Syndrome and Toxic Epidermal Necrolysis; and change in normal 
body flora resulting in either infections such as oral or vaginal yeast infections 
and antibiotic associated diarrhea Clostridium difficile (Drugs.com, 2013). 
•! Over 140,000 (19%) of the emergency department visits are due to reactions 
to antibiotics yearly and almost 4 out of 5 (79%) antibiotic related emergency 
department visits are due to allergic reactions (CDC, 2014e). 
 
c)! Top three urgent antibiotic resistance threats in the United States 
The CDC has identified 18 antibiotic resistance threats in the United States (US) 
prioritizing them as urgent, serious, or concerning and suggests that aggressive 
action is necessary now to prevent current antibiotic resistance spread and the 
development of new resistance (CDC, 2014f). 
•! Clostridium difficile (C. difficile) resulting in hospitalization of 250,000 
people with 14,000 deaths yearly and $1 billion excess medical costs. 
•! Carbapenem-resistant Enterobacteriaceae (CRE) causing 9,000 healthcare 
associated infections yearly in which half of those with blood stream 
infections result in death.  
•! Drug-resistant Neisseria gonorrhoeae cases as high as 246,000 of the 820,000 
yearly cases (CDC, 2014f). 
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d)! Deaths attributable to antimicrobial resistance every year by 2050 
 
Source: Review on Antimicrobial Resistance (2014) 
•! Currently antimicrobial resistance results in 700,000 deaths/year worldwide.  
This map shows with a continued rise in resistance, by 2050 AMR would lead 
to 10 million deaths/year worldwide – costing the world up to 100 trillion 
USD.  The variation in deaths linked to how heavily the countries use 
antibiotics. 
 
3.! Factors contributing to antibiotic overuse 
Studies have shown providers were found to have inadequate knowledge 
about antibiotic prescribing (Abbo et al., 2011, 2012; Rezal et al., 2015), 
underestimate antibiotic resistance (Rezal et al., 2015) and some feel 
antibiotic resistance is a lower priority than their immediate patient needs 
(McCullough et al., 2015).  A literature review shows inappropriate 
prescribing of antibiotics has been attributed to several indirect, extrinsic and 
intrinsic factors. 
a)! Indirect factors. 
•! Provider uncertainty of diagnosis (Rezal et al., 2015; Rodrigues, Roque, 
Falcao, Figueiras, & Herdeiro, 2012). 
•! Communication skills (Rodrigues et al., 2015). 
b)! Extrinsic factors. 
•! Patient signs/symptoms (Lopez-Vazquez, Vazquez-Lago, & Figueiras, 2011; 
Rodrigues et al., 2012). 
•! Serious or critically ill patient (Abbo et al., 2011, 2012; Rezal et al., 2015). 
•! Decreased patient visit time (Rodrigues et al., 2012; Sanchez, Roberts, Albert, 
Johnson, & Hicks, 2014). 
c)! Intrinsic factors. 
•! Fear of missing infection (Abbo et al., 2011, 2012). 
•! Fear of patient complication (Lopez-Vazquez et al., 2011; Rodrigues et al., 
2012; Sanchez et al., 2014). 
•! Provider complacency or perception that patient wants antibiotics (Lopez-
Vazquez et al., 2011; Rezal et al., 2015; Rodrigues et al., 2012; Sanchez et al., 
2014). 
 
IV.! Antibiotic Prescribing 
1.! Global use of antibiotics 
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Source: Center for Disease Dynamics, Economics & Policy (2016) 
•! This map shows use of all antibiotics in 2010 across the world. 
•! The light blue colors with the least use increasing into darker blue colors as 
increased use is noted.   
•! The highest use found in South Africa with 37K units per 1000 
population; the US found in mid-range use of 22K units per 1000 
population; and the lowest use being in Indonesia with 3K units per 1000 
population. 
 
2.! Global antibiotic consumption 
 
 
 
•! Between 2000-2010 antibiotic consumption increased by 36% and in 2010 the 
highest consumer of antibiotics was India (1st), China (2nd) and USA (3rd). 
•! The top map (A) shows consumption of antibiotics in 2010 expressed in standard 
units (i.e., pill, capsule, or ampoule) per person – the lighter red color representing 
less consumption with color increasing in darkness representing increasing 
consumption. 
•! The bottom map (B) shows compound annual growth rate of antibiotic drug 
consumption between 2000 and 2010 – the blue colors showing a decrease and 
the red colors showing an increase.   
•! These maps are showing that in 2010 the US antibiotic consumption was 
55-75 standard units per person, from 2000 to 2010 there was a decrease 
of 2.5 to 4.0 in antibiotic consumption. 
 
Van Boeckel et al (2014) The Lancet Infectious Diseases 2014 14, 742-750DOI: 
(10.1016/S1473-3099(14)70780-7)  
 
3.! United States Outpatient Antibiotic Prescribing Trends/Patterns 
2013 with 268.6 million antibiotics prescribed = 849 prescriptions per 1000 persons 
(CDC, 2015a) 
1.! Most common category 
•! Penicillin: 60.8 million  
•! Macrolides: 51.0 million – interestingly macrolides have been 
associated with bacterial resistance (Suda et al., 2014). 
2.! Most common agent 
•! Amoxicillin: 53.3 million 
•! Azithromycin: 47.2 million– azithromycin is thought to be 
overprescribed due to it being conveniently packaged and its once a 
day short duration of treatment (Suda et al. 2014).  
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3.! Provider associated with prescribing most antibiotic 
•! Primary Care: 121.7 million 
•! Nurse Practitioners & Physician Assistants: 48.4 million 
•! Emergency Medicine: 14.3 million 
4.! Patient gender 
•! Female: 162.8 million 
•! Male: 104.8 million 
5.! Geographical regions – the geographic variation in US prescribing rates is 
difficult to make clear because the national antibiotic prescribing polices 
and treatment guidelines (Hicks et al., 2015) 
•! South: 111.7 million  
•! Midwest: 61.0 million  
•! Northeast: 49.0 million  
•! West: 47.0 million  
6.! Season  
•! The season most associated with increased antibiotic prescribing are 
the winter months’ when bacterial and especially viral illnesses are 
common.  
•! The winter months average 24.5% more antibiotics than summer  
•! Between 2006-2010 the winter months had 1.34 billion antibiotics 
prescribed (Suda et al., 2014) 
 
(http://www.cdc.gov/getsmart/community/images/usmap.jpg) 
(graphic CDC, 2016) 
 
4.! Antibiotic use in the USA 
 
Source: Center for Disease Dynamics, Economics & Policy (2016) 
•! This map shows US use of all antibiotics in 2012. 
•! MO used 995 standard units per 1000 population whereas the lease used was 
in Alaska at 553 standard units and the most used was in Kentucky at 1357 
standard units. 
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5.! Antibiotic use around the state of MO 
 
Source: Center for Disease Dynamics, Economics & Policy (2016) 
•! This chart shows a graph of antibiotic use in 2012 of MO and surrounding 
states.   
•! The tall yellow line representing all antibiotic use, blue is broad spectrum 
PCN, green is macrolides and purple is quinolones.  
•! MO shows comparable use of surrounding states, other than that of Kentucky 
and Alabama with higher use.  
 
6.! Provide feedback and discuss provider chart audit obtained 
•! A retrospective chart review of 16 physicians and 18 NPs was done for 6 of 
the 8 Urgent Care Clinics. 
•! Oct, Nov, and Dec 2015 150 charts were reviewed (99 Female patients and 51 
Male patients; 73 patients seen by NPs and 77 patients seen by Physicians).  
This chart audit revealed a total of 79 antibiotic prescriptions for acute 
respiratory infection resulting in a 53% antibiotic prescribing rate. 
a)! Most common category 
•! Macrolides: 39 
•! Penicillin:  29 
b)! Most common agent 
•! Azithromycin: 38 
•! Amoxicillin: 21 
c)! Provider associated with prescribing most antibiotic 
•! Physicians: 49 
•! Nurse Practitioners: 30 
d)! Patient gender 
•! Female: 52 with most at Winghaven (16) 
•! Male: 27 with most at Chesterfield (6) and Winghaven (6) 
e)! Center 
•! Winghaven: 22 
•! Chesterfield: 21 
f)! Diagnosis 
•! Bronchitis: 33 
•! URI: 25 
•! Pharyngitis/laryngitis: 21 
When compared to the 2013 US data, the top 2 categories and ages were the same 
except macrolides were prescribe more than penicillins.  Females received more 
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antibiotics than males. Yet physicians prescribed more antibiotics than nurse 
practitioners.  
 
V.! Acute Respiratory Infection Facts 
1.! Number of patients seen yearly for acute respiratory infections. 
•! Lee et al. (2014) revealed from 2000 to 2010 there were 3.1 billion outpatient ARI 
visits in the United States. 
•! In 2011, there was an estimated 8 million outpatient and emergency department 
(ED) visits for ARIs (CDC, 2014a, b, c, d). 
 
2.! Time frame of viruses. 
•! Adults get 2-4 times/year (Schellack et al. 2014)  
•! Children get 6-8 times/year (Havens & Schwartz, 2016) 
•! Viruses typically resolve with symptomatic treatment within 7-10 days (Schellack 
et al, 2014) 
 
3.! Antibiotics are not for viruses. 
•! Per definition, antibiotics are a type of antimicrobial drug used in the 
treatment of bacterial infections. 
•! Antibiotics are not for viruses!!! 
 
4.! Sputum color – No benefit from antibiotic treatment. 
 
(Cleveland Clinic, 2014) 
a)! 1952 analysis of green sputum (Robertson, 1952) 
•! Wanted to know why is sputum green color in patients diagnosed with 
bronchiectasis – is it due to bacterial involvement? 
•! Spectrophotometric analysis revealed green color due to failure to excrete 
verdoperoxidase (green color enzyme from white blood cells) and is due to the 
stagnation (not coughing much) of the purulent sputum. 
•! He found green color sputum is rarely due to bacterial infection. 
b)! 2009 (Altiner et al., 2009) 
•! Examined 241 sputum samples of acute cough of 1 to 21-day duration (mean 
8 days) 
•! Only 29 (12%) of the samples revealed bacterial infection 
•! They found color of sputum to be a weak diagnostic predictor of bacteria 
•! They conclude that in those without underlying chronic lung disease, sputum 
color does not imply need for antibiotic  
c)! 1976 study (Scott & West, 1976) 
•! 207 adults with productive cough up to 1-week duration 
•! With treatment doxycycline or placebo x 10 days 
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•! They found otherwise healthy adults get better as quickly without antibiotic 
d)! 2011 study (Butler et al., 2011) 
•! 2,419 >= 18 year olds with cough as main symptom <= 28 days 
•! With treatment antibiotic or placebo 
•! Patients with discolored sputum showed increase in antibiotic prescribing 
•! Patients with COPD (67.4%), asthma (57.9%), >65 years (54.5%) had 
antibiotics prescribed 
•! They conclude that symptom resolution or any benefits are not associated with 
antibiotic treatment in patients with discolored sputum 
e)! 2013 study (Llor et al., 2013) 
•! 345 18 to 70-year-old patients with acute bronchitis < 1-week duration and 
purulent sputum 
•! With treatment ibuprofen, Augmentin or placebo x 10 days 
•! Number of days with frequent cough: ibuprofen 9d, Augmentin 11 days, 
placebo 11 days 
•! Duration of symptoms: ibuprofen 10 days, placebo 13 days 
•! They conclude that antibiotics are not associated with likelihood of cough 
resolution or shorten duration of cough 
 
5.! Recent study and National Guidelines 
•! A study by Fleming-Dutra and colleagues (2016) analyzed antibiotic 
prescribing among US ambulatory care visits 2010-2011 and found 154 
million prescriptions for antibiotics were written.  Out of a sample of 184 
thousand visits, 12.6% resulted in an antibiotic prescription, with an 
estimated 506 antibiotic prescriptions per 1000 population annually and acute 
respiratory infections associated with 221 antibiotic prescriptions per 1000 
population.  The top 3 diagnoses associated with antibiotics were sinusitis 
(56 Rx/1000 pop), suppurative otitis media (47 Rx/1000 pop) and pharyngitis 
(43 Rx/1000 pop). 
•! National guidelines state that patients with bronchiolitis, viral upper 
respiratory tract infections, asthma and allergy, influenza, viral pneumonia, 
non-suppurative otitis media and bronchitis (excluding visits with diagnosis 
of chronic bronchitis, emphysema, or chronic obstructive pulmonary disease) 
should not receive antibiotics (Fleming-Dutra, et al. 2016) 
 
6.! Common Cold and Acute Purulent Rhinitis. 
a)! Cochrane review (Kenealy, 2013) 
•! Chart review from 1950 to 2002 found 11 Randomized Control Trial 
studies (6 colds and 5 purulent rhinitis) 
•! Studies compared antibiotic treatment against placebo 
•! They found no benefit from antibiotic with cure or persistence of 
symptoms 
•! Also, there were greater side effects with using antibiotics in adults 
b)! URI – symptoms may last 10-14 days (CDC, 2015b) with mild cough persisting 
for 2-3 weeks (Snellman et al., 2013) 
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c)! Sinusitis – 9 of 10 cases in adults and 5-7 of 10 cases in children are viral (CDC, 
2015c) 
 
7.! Pharyngitis. 
a)! Cochrane review (Spinks, Glasziou & Del Mar, 2013) 
•! Chart review from 1950 to 2003 (7 studies 1996 to 2003) found 27 
Randomized Control Trial studies 
•! Studies compared antibiotic treatment against placebo 
•! They found sore throat and fever were reduced by ½ with antibiotic; 
with only a shortened duration of symptoms by 16 hours 
•! They also found with placebo: sore throat disappeared after 3 days 
(40%), fever disappeared after 3 days (85%), and 82% were symptom 
free by 1 week 
b)! Caused by virus in 80-90% of cases (Salkind & Wright, 2008) 
c)! If you have a negative rapid strep, please do not prescribe antibiotics 
d)! Viral causes of pharyngitis (Alcaide & Bisno, 2007) 
 
Viral causes 
Coxsackie Epstein Barr Cytomegalovirus 
HIV Influenza Rhinovirus 
Coronavirus Adenovirus Herpes 
 
e)! Pharyngitis in 10-30% is caused by Strep A with only 10-15% cases in 
adults (Llor, Madurell, Balagué-Corbella, Gómez, & Cots, 2011) 
f)! Bacterial of causes of pharyngitis (Alcaide & Bisno, 2007) 
 
Bacterial causes 
Strep A, C, G Gonorrhea Chlamydia 
Diphtheria Pneumonia Enterocolitis 
Plague Secondary 
Syphilis 
Tularemia 
 
8.! Bronchitis. 
a)! Cochrane review (Smith, Fahey, Smucny, & Becker, 2014) 
•! Chart review from 1970 to 2013 found 17 Randomized Control Trial 
studies  
•! Studies compared antibiotic treatment against placebo or no treatment 
•! They excluded patients with COPD/chronic bronchitis 
•! They found no benefit from antibiotic with cure 
•! They also discovered that those who received antibiotic only recovered 
½ day sooner (over 8-10-day period) in decreasing cough 
b)! 90% are non-bacterial (CDC, 2015d) 
c)! Chest x-ray warranted if temp >38 C, respirations >24, pulse >100, adventitious 
lung sounds (rales, egophony, fremitus) (CDC, 2015d) 
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VI.! Helpful Resources 
•! Guidelines focused on acute respiratory infections have been developed to 
assist providers in managing illnesses by detailing symptoms and differential 
diagnoses, reducing unnecessary antibiotic use and improving first line 
antibiotic use for antibiotic appropriate infections by providing treatment 
recommendations, and fostering provider-patient communication with tips and 
comfort measures to convey to patients. 
1.! Clinical PEARLS. 
Developed by Michigan Antibiotic Resistance Reduction Coalition (2004) – 
This is a 1-page document discussing illness facts, OTC treatments, patient 
communication strategies by utilizing PEARLS (partnership, empathy, 
apology, respect, legitimation, and support), and helpful statements to 
communicate to patients. 
 
Clinical PEARLS to Avoid Unnecessary use of Antibiotics 
Download PEARLS PDF 
 
2.! Evidence-based practice guidelines. 
This document was done by Snellman et al. (2013) - It has multiple diagnoses 
in algorithm form with treatment recommendations and provide patient 
information.  This document can be printed and but the online version is easier 
to use and has interactive links on the algorithm.  
 
Health Care Guideline Diagnosis and Treatment of Respiratory Illness in Children 
and Adults 
 
3.! Alliance Working for Antibiotic Resistance Education (AWARE). 
This was developed by the California Medical Association (2016) – These brochures 
are 2 page guidelines, discuss multiple illnesses, when and when not to treat with 
antibiotics, pathogens of illnesses 
Acute Respiratory Tract Infection Guideline Summary - Adult 
Acute Respiratory Tract Infection Guideline Summary - Pediatric 
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4.! CDC. 
Developed by the CDC (2015e) – The CDC wants the public to get smart 
about antibiotics these 2-page patient brochure inform about using antibiotic 
wisely 
Cold or Flu. Antibiotics Don't Work for You 
 
 
VII.! Stewardship 
Antibiotic stewardship is an interventional program for healthcare providers to enhance 
knowledge of antibiotic resistance and promote principles of responsible antibiotic use to 
preserve antibiotic effectiveness and decrease resistance (CDC, 2014f). 
1.! Interagency Task Force on Antimicrobial Resistance 
•! In March 2015, the Interagency Task Force on Antimicrobial Resistance 
developed the National Action Plan for Combating Antibiotic-Resistant Bacteria 
•! This plan provides a roadmap to detect, prevent, and control antibiotic 
resistance by guiding activities to improve antimicrobial stewardship with 
a goal of reducing outpatient inappropriate antibiotic use by 50% by 2020 
(The White House, 2015). 
2.! CDC program. 
•! In 2003, the CDC devised the Get Smart: Know When Antibiotics Work program 
to educate healthcare providers and the public about the importance of appropriate 
antibiotic prescribing.  
•! Since the initiation of the Get Smart program, The National Ambulatory Medical 
Care Survey reports that the program has produced a 25% reduction in outpatient 
antibiotic use for viral infections and 13% reduction in antibiotic prescribing 
(CDC, 2013). 
3.! Reducing Outpatient Antibiotic Resistance (ROAR) DNP project.  
A review of the literature revealed antibiotic stewardship interventions resulted in 
4.2% to 11.6% reduction in antibiotic prescribing (Grover et al., 2013; van der 
Velden et al., 2012). Since the urgent care centers do not currently have an outpatient 
antibiotic stewardship program the Reducing Outpatient Antibiotic Resistance project 
was developed.  
The project is a quasi-experimental Theory-based intervention on antibiotic 
prescribing.   
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a)! The purpose of the project is to evaluate the effect of an antibiotic 
stewardship program on urgent care providers’ antibiotic prescribing for 
acute respiratory infections and to assess providers’ knowledge and 
attitude concerning antibiotic use and resistance. 
b)! Outcomes to be measured include 
•! Provider antibiotic prescribing rates pre- and post-intervention 
•! Differences in antibiotic prescription rates of the diverse providers and 
•! Provider attitude and knowledge regarding antibiotic prescribing and 
resistance.   
 
VIII.! Patient Communication 
1.! Strategies. (Hicks, 2010) 
a)! Provide specific diagnosis 
•! Say “viral URI” or “viral bronchitis” 
b)! Offer symptomatic relief therapy 
•! Use of ibuprofen/acetaminophen can decrease fever, headaches, body aches to 
help feel better 
•! Give prescription for OTC medicines if feel that patient does not want to leave 
empty handed 
c)! Voice what is seen during exam 
•! Ears are not red, bulging or with fluid behind them 
•! Lungs are clear (have noted helps a lot with elderly reassurance) 
d)! Inform about antibiotic side effects and increased resistance 
•! Can give patient brochure from the CDC 
•! Discuss information discussed earlier – try saying “Antibiotics are 
only for bacterial infections.  Increased use has led to antibiotic 
resistance – a global public healthcare crisis that reduces the efficacy 
of antibiotics to adequately treat bacterial infections” 
e)! Advise on what to expect with illness to reassure them 
•! Tell them on average how long symptoms might last - I do tell them that 
everyone’s body has different way reacting to infections.  I also try to estimate 
duration of illness in other patients I have seen. 
•! Good to let those with bronchitis know that cough can last for a long time (4-6 
weeks) so they will not be alarmed 
•! Give a plan of action if don't improve or worsen 
f)! Reassure the patient 
•! Tell them that you understand how bad they feel 
•! Give a plan of action if don't improve or worsen 
 
2.! Learn how to say “No” and teach, teach, teach. (Chesanow, 2016) 
a)! Put no in an explanation 
•! Be diplomatic and less confrontational 
•! ‘You do not need an antibiotic because this is viral and antibiotics do not treat 
viruses nor will they help you get better’ 
b)! Open a discussion and explain 
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•! Try to find out why they want antibiotic 
•! If they say they got one last time, assure that it is viral and symptoms should 
resolve shortly 
c)! Be willing to negotiate 
•! Offer explanation of why what they want is incorrect and provide alternative 
•! If they have tried OTC treatments say ‘since you’re not feeling better, let’s 
discuss other options that aren’t antibiotics’ 
d)! Be a cheerleader 
•! Tell them they are doing the correct thing and sometimes resolution of 
symptoms takes time 
e)! Show patient’s empathy and compassion 
•! Acknowledge they are sick and let them know you understand their frustration 
•! ‘I’m sorry you are sick and feel bad’ 
•! ‘You look ill; it must be hard to get things done’ 
f)! Be firm when needed 
•! Gently put your foot down 
•! ‘I’m sorry, antibiotics are not for viruses’ 
 
IX.! Conclusion 
1.! Antibiotic resistance is global public health crisis. 
Antibiotic resistance is a global public health crisis reducing the efficacy of 
antibiotics to adequately treat infections, increasing patient mortality and 
skyrocketing healthcare costs (CDC, 2013; Center for Disease Dynamics, 
Economics & Policy, 2015; IOM, 2010; World Health Organization [WHO], 
2014). 
 
2.! Antibiotics are not for treatment of viruses. 
Antibiotics in their own right are beneficial and have a purpose – that of treating 
bacterial infections to improve health and prevent mortality 
 
(http://www.cdc.gov/getsmart/community/images/materials/improve-prescribing.jpg) 
(graphics CDC, 2016) 
 
3.! Antibiotic stewardship to decrease antibiotic prescribing. 
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•! Antibiotic stewardship primary goal is better patient care, reducing 
antibiotic use and saving money are just desirable side effects.   
•! To preserve antibiotic effectiveness and slow the progression of antibiotic 
resistance, coordinated interventions involving healthcare providers can be 
provided through antibiotic stewardship programs (CDC, 2013; Griffith, 
Postelnick, & Scheetz, 2012).   
•! The Reducing Outpatient Antibiotic Resistance (ROAR) theory-based 
intervention is an evidence-based DNP project created to reinforce 
providers’ confidence by enhancing knowledge in their ability to manage 
ARIs without antibiotics. 
4.!  
 
5.! Patient communication and education are the keys. 
•! The importance of how treatment recommendations are delivered during a 
visit for acute respiratory infections help to avoid unwarranted antibiotic 
prescribing. 
•! Communicate with patients utilizing PEARLS (partnership, empathy, 
apology, respect, legitimation, support) along with the strategies discussed 
and learn how to say “No”.  
•! Don’t forget to provide patient handouts explaining antibiotics – when 
they are not needed and risks involved in use. 
 
(http://www.cdc.gov/getsmart/community/images/materials/six-facts-graphic.png) 
 
(graphics CDC, 2016) 
X.! Cartoons 
1.! Batman and Robin. 
 
From “Batman on flu season,” by WeKnowMemes, LLC, 2013 
(http://weknowmemes.com/2013/01/batman-on-flu-season/). Reprinted with 
permission. 
 
2.! Antibiotic Resistance. 
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From “Antibiotic resistance,” by Nick D. Kim, 2015 (http://www.lab-
initio.com/a.html). Reprinted with permission. 
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Appendix L1 
Intervention Material 
 
Figure L1: Guidelines for common acute respiratory infections for adults.  Reprinted from 
California Medical Association Foundation: Aware, by California Medical Association, 2016, 
Retrieved June 27, 2016, from http://www.thecmafoundation.org/Programs/AWARE. Reprinted 
with permission.  
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Appendix L1 
Intervention Material 
 
Figure L1: Guidelines for common acute respiratory infections for pediatrics.  Reprinted from 
California Medical Association Foundation: Aware, by California Medical Association, 2016, 
Retrieved June 27, 2016, from http://www.thecmafoundation.org/Programs/AWARE. Reprinted 
with permission. 
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Appendix L2 
Intervention Material 
 
Figure L2. Brochure for patients. Reprinted from Get smart about antibiotics: Print material for 
adults, by CDC, 2015, Retrieved June 27, 2016, from 
http://www.cdc.gov/getsmart/community/materials-references/print-materials/adults/index.html.  
Reprinted with permission.  
  
?
Antibiotics Aren’t Always  
the Answer
Most illnesses are caused by two kinds of 
germs: bacteria or viruses.  Antibiotics can 
cure bacterial infections – not viral infections.
Bacteria cause strep throat, some pneumonia 
and sinus infections.  Antibiotics can work.
Viruses cause the common cold, most 
coughs and the flu.  Antibiotics don’t work.
Using antibiotics for a virus:
r 8JMM/05DVSFUIFJOGFDUJPO
r 8JMM/05IFMQZPVGFFMCFUUFS
r 8JMM/05LFFQPUIFSTGSPNDBUDIJOH
 ZPVSJMMOFTT
Protect Yourself 
With the Best Care
You should not use antibiotics to treat the common cold or the flu.
If antibiotics are prescribed for you to treat  
a bacterial infection – such as strep throat – be 
sure to take all of the medicine.  Only using 
part of the prescription means that only part of 
the infection has been treated. Not  finishing 
the medicine can cause resistant bacteria to 
develop.
 Talk to Your Healthcare  
Provider to Learn More
Commonly Asked 
Questions:
How Do I Know if I Have a  
Viral or Bacterial Infection?
Ask your  healthcare provider and follow his or 
her advice on what to do about your illness.
Remember, colds are caused by viruses and 
should not be treated with antibiotics.
Won’t an Antibiotic Help Me Feel 
Better Quicker so That I Can Get 
Back to Work When I Get a Cold 
or the Flu?
No, antibiotics do nothing to help a viral  
illness.  They will not help you feel better 
sooner.  Ask your healthcare provider what 
other treatments are available to treat your 
symptoms.
If Mucus from the Nose 
Changes from Clear to Yellow or 
Green — Does This Mean  
I Need an Antibiotic?
No. Yellow or green mucus does not mean that 
you have a bacterial infection.  It is normal for 
mucus to get thick and change color during a 
viral cold.
WIFOZPVGFFMTJDLZPVXBOUUPGFFMCFUUFSGBTU#VUBOUJCJPUJDTBSFOUUIFBOTXFS
GPSFWFSZJMMOFTT5IJTCSPDIVSFDBO
IFMQZPVLOPXXIFOBOUJCJPUJDTXPSLm
BOEXIFOUIFZXPOU'PSNPSF
JOGPSNBUJPOUBMLUPZPVSIFBMUIDBSF
QSPWJEFSPSWJTJUXXXDEDHPWHFUTNBSU
The Risk:  
Bacteria Become Resistant 
What’s the harm in taking antibiotics  
anytime?  Using antibiotics when they are  
not needed causes some bacteria to become 
resistant to the antibiotic. 
These resistant bacteria are stronger and 
harder to kill.  They can stay in your body and 
can cause severe illnesses that cannot be cured 
with antibiotics.  A cure for resistant bacteria 
may require stronger  treatment – and possibly 
a stay in the hospital.
To avoid the threat of antibiotic-resistant  
infections, the Centers for Disease Control 
and Prevention (CDC) recommends that  
you avoid taking unnecessary  
antibiotics. 
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Appendix L3 
Intervention Material 
 
Figure L3. Clinical PEARLS.  Reprinted from Information and Resources for Healthcare 
Providers: MARR, by Michigan Antibiotic Resistance Reduction Coalition, 2004, Retrieved June 
27, 2016, from http://www.mi-marr.org/provider.php.  Reprinted with permission.  
Common Scenarios
• I have to have an antibiotic.
• An antibiotic is the only thing that ever helps.
• Amoxicillin doesn’t work … I need Biaxin (or other drug)
• But it always settles in my chest/sinuses.
• I can’t afford to be sick.
• I’m going on a trip.
• My spouse is on Biaxin.
• My co-workers/ sent me in to get an antibiotic.
• The daycare won’t take her without antibiotics.
• I feel awful.
• I have drainage – it’s green/bloody/choking me.
Communication Strategies 
for Discussing Viral Illness with Patients
1. Use PEARLS.
2. Comment on pertinent positive and negative physical findings as
exam proceeds.
3. Make reference to popular news articles or other media reports
about antibiotics assuming patient is aware of their content.
4. Don’t pressure yourself to convince 100% of your patients.
Remember your success in prescribing antibiotics appropriately.
Keep in mind that many patients will become convinced over time
about proper use of antibiotics.
5. For patients who insist on an unnecessary antibiotic, offer the
prescription and explain that you care about the patient, but do not
support using the antibiotic on medical grounds.
6. For patients whose illness poses diagnostic uncertainty or logistical
concerns (travelling, etc), try these suggestions:
• Offer the prescription and provide instructions describing under 
what circumstances it would be appropriate to fill it and initiate 
the antibiotic.
• Suggest the patient call your office in a few days if not better or 
getting worse.  Be sure to provide the patient with an easy 
mechanism for reaching you (voice mail, beeper, specific nurse or 
medical assistant contact, etc).
• Suggest patient return if not improved in a few days.
• Promise to call the patient in a few days and DO IT.
7. Make an effort to understand the context of the illness in the
patient’s life and how the patient feels the illness will affect
him/her.  This may yield clues for suggesting treatment that does
not include an antibiotic.
8. Provide education - Explain the natural course of the illness
including time markers.  Consider showing the patient the CDC
symptom v. time graph of upper respiratory infections.
9. Put forth an expression of hope.
PEARLS Strategy
Description and Helpful Statements
PARTNERSHIP: Joint problem solving
•  Let’s tackle this together.
E MPATHY: Show understanding, put feelings into words
• That sounds hard.
• You look upset.
• You seem discouraged.
• Help me to understand what these symptoms are about.
• How has this affected you?
• You look so ill today; it must be so hard to accomplish anything.
A POLOGY: Show compassion about illness
• I’m sorry you’re feeling ill.
R ESPECT: Value patient’s choices,traits,behaviors and 
special qualities
• I appreciate your decision/action.
• You did the right thing by coming in today.
• What do you think is going on?
• What do you think will help?
• You may need an antibiotic, but first let’s see what your 
exam shows.
• I’m sure you’ve seen reports about bacterial resistance caused 
by improper use of antibiotics.
• Biaxin (or other drug) is a good antibiotic.  It’s very popular 
because it’s been heavily advertised.  But I think amoxicillin (or
other drug) is better for your illness.
L EGITIMATION: Normalize and validate feelings and choices
• Anyone would be irritated/miserable with this situation.
•  We’re seeing a lot of this illness (cold, flu, virus) lately.
•  It’s difficult for most people to tell the difference between a
cold, flu, sinus infection or an allergy flare.
•  I can see how you would feel that way.
• You do have a lot of drainage (or other complaint).
S UPPORT: Offer ongoing support
•  I’ll stick with you as long as necessary.
•  I’m going to help you manage this.
•  Let me offer you some helpful suggestions.
•  Do you need a work note?
Avoiding Unnecessary Use of Antibiotics
Rhinitis/Sinusitis (URI)
• Children have 6-8 viral URI per year; adults have 2-3 per year.
Only 0.5% of viral URI are complicated by bacterial infection.
• In uncomplicated colds, cough and nasal discharge may persist
for 14 days or more, long after other symptoms have resolved.
• Mucopurulent rhinitis (thick, opaque or discolored nasal
discharge) frequently accompanies viral URI.  It is not an
indication for antibiotic treatment unless it persists without
improvement for 10 - 14 days.
• Antibiotics do not effectively prevent subsequent bacterial infection.
Pharyngitis
• Only 15% of pharyngitis is caused by group A strep; most sore
throats are caused by viral agents.
• Prominent rhinorrhea, cough, hoarseness, conjunctivitis or 
diarrhea with sore throat suggests viral etiology for pharyngitis.
• Penicillin is the drug of choice for pharyngitis; no group A s t re p
a re resistant to penicillin. Use erythromycin for penicillin-allerg i c
p a t i e n t s .
Cough and Bronchitis
• Bronchitis in children and adults rarely warrants antibiotic
treatment; if non-viral illness is suspected (underlying lung
disease?), erythromycin or doxycycline can be used.
Seven studies have identified recent antibiotic use as a risk factor for
development of infection with resistant pneumococci. To pre v e n t
bacterial resistance, avoid unnecessary use of antibiotics. Plan tre a t -
ment of symptoms for your patients presenting with viral illness.
OTC Symptom Relief Medications
Symptom Medication Active ingredients Examples
Stuffy nose Decongestant Pseudoephedrine Sudafed
Phenylpropanolamine Propagest
Cough Cough Dextromethorphan Vicks 
suppressant Formula 44
Chest Expectorant Guaifenesin Robitussin
congestion
Sore throat Lozenge Benzocaine Cylex
Glycerin Vicks
Chloraseptic
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Appendix M 
Reinforcement Material 
 
Figure M1. Provider reminder number 1.  Reprinted from Get Smart: Know When Antibiotics 
Work: Graphics – Improving Antibiotic Prescribing, by CDC, 2016, November 2, 2016, from 
https://www.cdc.gov/getsmart/community/images/materials/improve-prescribing.jpg. Reprinted 
with permission. 
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Appendix M 
Reinforcement Material 
 
Figure M2. Provider reminder number 2. Reprinted from Get Smart About Antibiotics Week: 
Print products, by CDC, 2016, Retrieved November 15, 2016, from 
https://www.cdc.gov/getsmart/week/downloads/ad-hcp-w-links.pdf. Reprinted with permission. 
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Appendix M 
Reinforcement Material 
   
 
Figure M3. Provider reminder number 3. Reprinted from Get Smart: Know When Antibiotics 
Work: Print material for Healthcare Professionals, by CDC, 2016, Retrieved December 7, 2016, 
from https://www.cdc.gov/getsmart/week/downloads/gsw-factsheet-providers.pdf. Reprinted 
with permission. 
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Appendix M 
Reinforcement Material 
 
Figure M4. Provider reminder Number 4. 
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Appendix N 
Intervention Flow Design 
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Appendix O 
Application of Change Theory 
 
Figure O1. DNP project change theory. This figure illustrates effective elements in Kurt Lewin’s 
change theory applied to the DNP intervention.  Adapted from an image by Lundberg (2010).  
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Appendix P 
Project Timeline 
Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec Jan Feb Mar Apr May
SELECT;A;TOPIC
Identify;practice;problem;&;develop;PICOT;question
FORM;A;TEAM
Discuss;DNP;project;with;managers;of;urgent;care;centers
RETRIEVE;RELEVANT;RESEARCH;EVIDENCE
Conduct;comprehensive;literature;review
CRITIQUE;AND;SYNTHESIZE;RESEARCH
Critically;appraise;literature;and;summarize;evidence
Choose;EBP;model;&;theoretical;conceptual;framework
PROJECT;DESIGN
Formulate;detailed;plan;for;implementation;of;evidence
Design;study;&;develop;methods
Write;research;proposal
Present;proposal;to;UMKC;faculty
Acquire;IRB;approval;for;project;implementation;&;dissemination
PROJECT;EXECUTION
Implement;DNP;project:;recruitment;of;participants
Collect;&;collate;preWintervention;data;(chart;audit)
Distribute,;analyze;&;interpret;provider;questionnaire;&;demographics
ROAR;educational;program;W;live;and;video;presentation
Collect;&;collate;postWintervention;data;(chart;audit)
PROJECT;EVALUATION;&;REPORTING
Disseminate;project;proposal:;poster;at;APNO;Conference
Analyze;data;(chart;audit:;preW;&;postWintervention);&;interpret;findings
Disseminate;findings:;executive;summary;to;IRB,;study;providers;&;
management\;poster;at;UMKC;Student;Research;Summit\;manuscript;to;
Journal(of(Doctoral(Nursing(Practice
Task
2016 2017
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Appendix Q 
 
Logic Model for DNP Project 
!
PICOTS:!In healthcare providers at urban urgent care centers, does an antibiotic stewardship program Reducing Outpatient Antibiotic Resistance compared to the current practice of no program 
reduce the prescribers' inappropriate use of antibiotics to treat ARIs and change healthcare providers’ knowledge and attitudes regarding antibiotic use resistance within four months following the 
antibiotic stewardship program?!
Inputs! ! Intervention(s)!!!!!!!!!!!!!!!!!!!!!!!!Outputs! ! Outcomes!77!Impact!! Activities! Participation! ! Short0 Medium0 Long0
Evidence, sub-topics 
 
Understanding healthcare provider 
antibiotic prescribing behavior.  
 
Knowledge, attitudes and practices 
(KAP) among healthcare providers 
regarding antibiotic use & 
resistance. 
 
Evidence-based guidelines for 
treatment of acute respiratory 
infections.  
 
Interventions to reduce healthcare 
provider antibiotic prescribing for 
acute respiratory infections. 
 
•! Provider education. 
•! Provider feedback. 
•! Provider decision support 
system. 
•! Guidelines. 
•! Communication skills 
training. 
 
Major Facilitators or 
Contributors 
 
Urgent care center MD & NP 
managers. 
 
Major Barriers or Challenges 
Healthcare providers in the urgent 
care centers 
Hospital administrators.!
! EBP intervention which 
is supported by the 
evidence in the Input 
column  
 
Reducing outpatient 
antibiotic resistance 
stewardship program. 
 
Major steps of the 
intervention   
 
Chart review to obtain 
antibiotic prescribing rate 
for acute respiratory 
infections. 
 
Administration of survey 
to assess factors 
influencing healthcare 
provider prescribing 
behavior. 
 
Presentation of 
stewardship program. 
 
Chart review to obtain 
antibiotic prescribing rate 
for acute respiratory 
infections 2-3 months 
after stewardship 
program.   
 
Comparison of post-
intervention chart audit 
to baseline chart audit. 
The participants 
(subjects)   
 
Healthcare 
providers: doctors 
and nurse 
practitioners. 
 
Site 
 
Eight urgent care 
centers in large 
metropolitan area in 
MO. 
 
Time Frame  
Estimated 3-4 
months. 
 
Consent Needed 
or other 
Informed consent 
from each 
participant. 
 
Person(s) 
collecting data 
 
Student 
investigator. 
 
Others directly 
involved   
 
None. 
! (Completed as student)  
Outcome(s) to be measured with valid 
& reliable tool(s)  
Antibiotic prescribing rates for acute 
respiratory infections. Case report 
spreadsheet designed. 
 
Differences in acute respiratory infection 
antibiotic prescribing rates between MD 
& NP providers. Case report spreadsheet. 
 
Attitude & knowledge regarding 
antibiotic prescribing & resistance.  KAP 
survey developed by Rodrigues et al. 
(2016). 
 
Statistical analysis to be used  
Power analysis to estimate number of 
patient charts required to detect significant 
change. 
 
Antibiotic prescribing rates determined by 
proportion of visits for acute respiratory 
infections with a prescription for antibiotic. 
 
Wilcoxon Sign rank, McNemar’s and Chi-
square tests to detect differences between 
pre- & post-intervention antibiotic 
prescribing rates. 
 
Frequency distribution table reporting 
provider demographics. 
 
Mann-Whitney U test to assess attitudes, 
factors that influence antibiotic prescribing 
and most/least important source of 
knowledge.!
(after student DNP)  
Outcomes to be 
measured  
 
Antibiotic 
prescribing rates via 
random chart audits 
on a quarterly or 
biannual basis. 
 
Broad-spectrum 
antibiotic use for 
acute respiratory 
infections. 
 
 
 
 
 
 
 
 
(after student DNP) 
Outcomes that are 
potentials  
 
Patient return visit (≤ 
30 days from incident 
visit) rates. 
 
Adverse events 
within 30 days of 
index visit. 
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Appendix R1 
Patient Chart Spreadsheet Template 
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Appendix R2 
Acceptable ICD-10 Codes 
ICD–10 Code Diagnosis 
J00 Acute nasopharyngitis (common cold) 
J02 Acute pharyngitis 
J02.8 Acute pharyngitis due to other specified organisms 
J02.9 Acute pharyngitis unspecified 
J03 Acute tonsillitis 
J03.8 Acute tonsillitis due to other specified organisms 
J03.9 Acute tonsillitis unspecified 
J04 Acute laryngitis tracheitis 
J04.0 Acute laryngitis 
J06 Acute URI multiple unspecified sites 
J06.0 Acute laryngopharyngitis 
J06.9 Acute URI unspecified 
J09.X Flu due to id novel influenza A 
J10 Flu due to id seasonal flu 
J10.1 Flu other respiratory manifest seasonal flu id 
J11 Flu virus not id 
J11.1 Flu other respiratory manifest id 
J20 Acute bronchitis 
J20.8 Acute bronchitis due to other specified organisms 
J20.9 Acute bronchitis unspecified 
J21 Acute bronchiolitis 
J21.8 Acute bronchiolitis due to other specified organisms 
J21.9 Acute bronchiolitis unspecified 
J22 Unspecified lower respiratory infection 
J30 Vasomotor allergic rhinitis 
J30.0 Vasomotor rhinitis 
J30.1 Allergic rhinitis due to pollen 
J30.2 Other seasonal allergic rhinitis 
J30.3 Other allergic rhinitis 
J30.4 Allergic rhinitis unspecified 
J39 Other diseases upper respiratory tract 
J39.98 Other specified diseases of upper respiratory tract 
J39.9 Disease upper respiratory tract unspecified 
Note. ICD–10 = International Classification of Diseases, 10th Revision, URI = upper respiratory 
infection. 
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Appendix R3 
Excluded ICD-10 Codes 
ICD–10 Code Diagnosis 
J01.0 to J01.9 Acute sinusitis 
J02.0 Streptococcal pharyngitis 
J03.0 Streptococcal tonsillitis 
J05.0 Acute obstructive laryngitis (croup) 
J05.1 Acute epiglottitis 
J12 to J18 Pneumonia 
J31 to J37 Chronic diseases of upper respiratory tract 
J38.0 to J38.7 Diseases of vocal cords and larynx, not elsewhere classified 
J39.0 to J39.9 Other diseases of upper respiratory tract 
J40 to J47 Chronic lower respiratory diseases 
H65 to H75 Diseases of middle ear and mastoid 
Note. ICD–10 = International Classification of Diseases, 10th Revision. 
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Appendix S 
Provider and Patient Spreadsheet Template 
Provider Code 
    
    
    
    
 
Patient ID Patient Initials Code 
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Appendix T 
Healthcare Provider Questionnaire 
 
Figure T1.  Provider questionnaire, page 1 of 2.  Developed by Rodrigues et al, 2016, 
http://link.springer.com/article/10.1186/s12879-015-1332-y. Reprinted with permission 
http://creativecommons.org/licenses/by/4.0/.  
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Appendix T 
Healthcare Provider Questionnaire 
 
Figure T2.  Provider questionnaire, page 2 of 2.  Developed by Rodrigues et al, 2016, 
http://link.springer.com/article/10.1186/s12879-015-1332-y. Reprinted with permission 
http://creativecommons.org/licenses/by/4.0/
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Appendix U 
KAP Questionnaire Spreadsheet Template 
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Appendix V 
Characteristics of Study Providers 
Characteristic Nurse Practitioner Physician 
Provider type, n (%) 5 (62.5) 3 (37.5) 
Sex, n (%)   
Male  1 (33) 
Female 5 (100) 2 (67) 
Years practicing, mean 4 23.33 
Years in UCC, mean 2.4 7.33 
Number of patients seen per day, mean 20.6 22.33 
Time (minutes) needed to see patient, mean 18.4 20 
Note. UCC = urgent care center. 
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Appendix W 
Comparison of Patient Encounters Before and After the ROAR Intervention 
Characteristic Pre-Intervention (N = 150) 
Post-Intervention 
(N = 156) 
Age, mean, range 37.19, 3 months-89 years 38.15, 1-86 years 
Duration of illness, mean, range 5.48, 0.25-30 days 5.23, 0.25-60 days 
Sex, n (%)   
Male 43 (28.7) 63 (40.4) 
Female 107 (71.3) 93 (59.6) 
Number of encounters, n (%)   
NP 90 (60) 100 (64.1) 
MD 60 (40) 56 (35.9) 
Patient primary PMH, n (%)   
1st None 72 (48) None 80 (51.3) 
2nd HTN 15 (10) HTN 24 (15.4) 
3rd Asthma 14 (9.3) Asthma 10 (6.4) 
Diagnosis, n (%)   
1st Pharyngitis 52 (34.67) URI 71 (45.52) 
2nd URI 47 (31.33) Pharyngitis 41 (26.28) 
3rd Bronchitis 42 (28) Bronchitis 38 (24.36) 
4th Tonsillitis 5 (3.33) Tonsillitis 2 (1.28) 
5th Laryngitis 3 (2) Laryngitis 2 (1.28) 
6th Common Cold 1 (0.67) Unspecified LRI 2 (1.28) 
Antibiotic prescribing rate, n (%) No Yes No Yes 
Total 105 (70) 45 (30) 126 (80.77) 30 (19.23) 
Male 25 (16.67) 18 (12) 50 (32.05) 13 (8.33) 
Female 80 (53.33) 27 (18) 76 (48.72) 17 (10.9) 
NP 72 (48) 18 (12) 89 (57.05) 11 (7.05) 
MD 33 (22) 27 (18) 37 (23.72) 19 (33.93) 
Diagnosis given antibiotic, n (%)   
1st Bronchitis 20 (13.4) Bronchitis 20 (12.8) 
2nd Pharyngitis 14 (9.3) URI 4 (2.6) 
3rd URI 9 (6) Pharyngitis 4 (2.6) 
Most prescribed antibiotic, n (%)   
1st Zithromax 20 (13.3) Zithromax 22 (14.1) 
2nd Amoxicillin 13 (8.67) Amoxicillin 4 (2.56) 
3rd Augmentin 3 (2) Doxycycline 3 (1.92) 
4th Keflex 3 (2) Augmentin 1 (0.64) 
Note. HTN = hypertension, LRI = lower respiratory infection, MD = physician, NP = nurse 
practitioner, URI = upper respiratory infection. 
  
ROAR INTERVENTION 137 
 
Appendix X 
 
Pre- and Post-Intervention Antibiotic Prescribing Rates 
 
Provider 
Pre-Antibiotic 
Prescribing 
Rate % 
Post-Antibiotic 
Prescribing 
Rate % 
Percentage 
Difference % 
Relative 
Reduction % 
Absolute 
Reduction % 
NP 15 0 200 -100 -15 
NP 20 25 22.22 25 5 
MD 60 65 8 8.33 5 
NP 45 15 100 -66.67 -30 
MD 35 0 200 -100 35 
NP 5 15 100 200 10 
NP 15 0 200 -100 -15 
MD 40 37.50 6.45 -6.25 -2.50 
Note: MD = physician, NP = nurse practitioner, percentage difference = {(pre – post)/[(pre + 
post)/2]} x 100, relative reduction = [(post – pre)/pre] x 100, absolute reduction = post – pre. 
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Appendix Y 
Antibiotic Prescribing Statistical Analysis Results 
Outcome Pre-Intervention 
Post-
Intervention p value 
Absolute 
Reduction 
Antibiotic prescribing rates     
All charts 30 % 20 % .078 10 % 
NP 20 % 12 % .210 8 % 
MD 45 % 34 % .327 11 % 
Preference in antibiotic prescribing     
Odds ratio of NPs preferring not 
to prescribe antibiotic 
3.273 
 
 .001  
Odds ratio of NPs preferring not 
to prescribe antibiotic 
 4.155 
 
< .0005  
Note. MD = physician, NP = nurse practitioner. 
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Appendix Z 
KAP Questionnaire Attitudes, Influencing Factors and Knowledge Results 
 Nurse Practitioner Physician All Providers p value 
ATTITUDES     
ABX resistance is problem in 
our setting, mean %, median % 
M = 89.60 M = 96.67 M = 92.25 .571 
Mdn = 98.00 Mdn = 100.00 Mdn = 99.00 
ABX resistance is problem 
nationally,  
mean %, median % 
M = 98.00 M = 93.67 M = 96.38 .786 
Mdn = 98.00 Mdn = 100.00 Mdn = 98.50 
ABX overused in our setting,  
mean %, median % 
M = 83.40 M = 86.67 M = 84.43 1.0 
Mdn = 89.00 Mdn = 85.00 Mdn = 87.00 
ABX overused nationally,  
mean %, median % 
M = 90.40 M = 88.33 M = 89.63 .786 
Mdn = 99.00 Mdn = 85.00 Mdn = 96.00 
Factors Influencing ABX 
Prescribing 
    
Greatest fear, Mdn % In case of doubt, 
preferable to use 
wide-spectrum ABX 
to ensure cure  
73 
Frequently prescribe 
ABX when 
impossible to 
conduct patient f/u  
65 
Frequently prescribe 
ABX when 
impossible to 
conduct patient f/u  
51 
.250 
Greatest complacency, Mdn % Sometimes prescribe 
ABX so patients 
continue to trust me  
31 
Frequently prescribe 
ABX because 
patients insist  
25 
Sometimes prescribe 
ABX so patients 
continue to trust me  
25 
.571 
Greatest ignorance, Mdn % Amoxicillin is useful 
for treating most 
respiratory infections  
62 
Amoxicillin is useful 
for treating most 
respiratory infections  
35 
Wait for micro 
results before 
treating infectious 
disease  
49.5 
.393 
Greatest indifference, Mdn % ABX prescribed due 
to no time to explain 
to patient why 
unnecessary  
34 
ABX prescribed due 
to no time to explain 
to patient why 
unnecessary  
11 
ABX prescribed due 
to no time to explain 
to patient why 
unnecessary  
21.5 
.036 
Greatest responsibility of 
others, Mdn % 
Dispensing ABX 
without prescription 
needs to be more 
closely controlled  
95 
Dispensing ABX 
without prescription 
needs to be more 
closely controlled  
97 
Dispensing ABX 
without prescription 
needs to be more 
closely controlled  
96 
1.0 
Sources of Knowledge     
Most important, Mdn % CEU  
85 
Specialists & CEU  
90 
CEU  
85 
1.0 
Least important, Mdn % Medical info officer  
45 
Internet  
50 
Internet  
50 
.571 
Note. ABX = antibiotic, CEU = continuing education unit, f/u = follow up, KAP = knowledge, 
attitude and practice, M = mean, Mdn = median.  
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Appendix Z2 
University of Missouri Kansas City School of Nursing and Health Studies Proposal Approval 
Letter 
 
 
 
 
July 18, 2016 
 
Members of the Institutional Review Board 
 
IRB,  
This letter serves to provide documentation regarding Cynthia Brown’s Doctor of Nursing Practice (DNP) 
Project proposal.  Ms. Brown obtained approval for her project proposal, Reducing Outpatient Antibiotic 
Resistance: A Quasi-Experimental Study, from the School of Nursing DNP faculty committee on July 18, 
2016.   
 
If I can provide any further information, please feel free to contact me. 
Sincerely, 
 
Susan J. Kimble, DNP, RN, ANP-BC, FAANP 
Clinical Associate Professor 
DNP Programs Director 
UMKC School of Nursing and Health Studies 
816-235-5962 
kimbles@umkc.edu 
